Page last updated: 2024-11-10

formononetin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID5280378
CHEMBL ID242341
CHEBI ID18088
SCHEMBL ID62915
MeSH IDM0051146

Synonyms (129)

Synonym
BIDD:ER0119
BRD-K55567017-001-02-4
formononetol
7-hydroxy-4'-methoxyisoflavone
7-hydroxy-3-(4-methoxyphenyl)-4h-chromen-4-one
4'-o-methyldaidzein
CHEBI:18088 ,
7-hydroxy-3-(4-methoxyphenyl)-4h-benzopyran-4-one
7-hydroxy-3-(4-methoxyphenyl)-4-benzopyrone
KBIO1_001263
DIVK1C_006319
NCI60_042081
SDCCGMLS-0066428.P001
nsc 93360
einecs 207-623-9
SPECTRUM_000373
SPECTRUM5_000258
tnp00176
NCGC00017269-01
OPREA1_815287
NCGC00178715-01
7-hydroxy-3-(4-methoxyphenyl)chromen-4-one
nsc93360
4h-1-benzopyran-4-one, 7-hydroxy-3-(4-methoxyphenyl)-
biochanin b ,
nsc-93360
isoflavone, 7-hydroxy-4'-methoxy-
OPREA1_139748
BSPBIO_002299
k-080
daidzein 4-methyl ether
C00858
formononetin ,
485-72-3
MLS000697593
smr000470932
NCGC00095207-03
NCGC00095207-02
NCGC00095207-01
KBIOGR_001878
KBIO2_003421
KBIO2_005989
KBIO3_001519
KBIO2_000853
KBIOSS_000853
SPECTRUM4_001429
SPECTRUM2_000560
SPBIO_000639
SPECPLUS_000223
NCIOPEN2_005983
SPECTRUM3_000660
SPECTRUM102007
7-hydroxy-4'-methoxy-isoflavone
formononetin, >=99.0% (tlc)
STK801612
AKOS000270811
mycotech
neochanin
flavosil
myconate
CHEMBL242341
HMS1922N18
LMPK12050037
bdbm50021398
295dqc67bj ,
unii-295dqc67bj
dtxcid502311
tox21_301848
NCGC00255167-01
dtxsid4022311 ,
cas-485-72-3
A827555
7-hydroxy-3-(4-methoxyphenyl)-1-benzopyran-4-one
BBL010458
7-hydroxy-3-(4-methoxyphenyl)chromone
F0868
AE-641/01968055
HMS2231I04
CCG-38727
NCGC00017269-04
NCGC00017269-05
NCGC00017269-02
NCGC00017269-03
FT-0632204
FT-0626540
NCGC00017269-06
F3139-1207
S2299
HMS3369C07
formononetin [usp-rs]
formononetin [mi]
7-hydroxy-3-(4-methoxyphenyl)-4h-1-benzopyran-4-one
formononetin (constituent of astragalus) [dsc]
formononetin [inci]
formononetin (constituent of red clover) [dsc]
AB00052676-07
HY-N0183
SCHEMBL62915
formononetine
MLS006011897
Q-100540
mfcd00016948
formononetin, analytical standard
SR-01000765510-4
SR-01000765510-3
sr-01000765510
AC-8001
formononetin, united states pharmacopeia (usp) reference standard
HMS3655N22
7-hydroxy-3-(4-methoxyphenyl)-4h-benzopyran-4-one(9ci)
7-hydroxy-4'-methoxy-isoflavone (8ci)
formoononetin
SW219915-1
NCGC00017269-07
formononetin (for)
Q408859
formononetin (formononetol)
DB15335
formononetin,(s)
AS-11642
BRD-K55567017-001-06-5
biochanin b; flavosil; formononetol; nsc 93360; nsc93360; nsc-93360
BCP29929
7-hydroxy-3-(4'-methoxyphenyl)-4h-benzopyran-4-one
EN300-116214
Z374511822
formononetin (constituent of astragalus)
formononetin (constituent of red clover)
formononetin (usp-rs)

Research Excerpts

Overview

Formononetin (FMNT) is an isoflavone that has been studied for its anti-hyperglycemic and anti-diabetic effects. It is a type of phytoestrogen obtained from the Chinese medical herb Red Clover.

ExcerptReferenceRelevance
"Formononetin is a natural product isolated from A."( Formononetin represses cervical tumorigenesis by interfering with the activation of PD-L1 through MYC and STAT3 downregulation.
Jiang, MW; Jin, CH; Jin, HL; Jin, X; Jin, Y; Li, MY; Ma, J; Piao, LX; Ri, M; Wang, JY; Xing, Y; Xu, GH; Zhang, ZH; Zuo, HX, 2022
)
2.89
"Formononetin (FMNT) is an isoflavone that has been studied for its anti-hyperglycemic and anti-diabetic effects. "( Formononetin reshapes the gut microbiota, prevents progression of obesity and improves host metabolism.
Naudhani, M; Ni, ZJ; Thakur, K; Wei, ZJ; Zhang, JG, 2021
)
3.51
"Formononetin is a type of phytoestrogen obtained from the Chinese medical herb Red Clover. "( Formononetin protects against inflammation associated with cerebral ischemia-reperfusion injury in rats by targeting the JAK2/STAT3 signaling pathway.
Chen, Q; He, Y; Wan, H; Yang, J; Yu, L; Zhang, Y; Zhou, H, 2022
)
3.61
"Formononetin is an isoflavone compound found in many traditional Chinese medicines that has a wide range of pharmacological activities. "( Molecularly imprinted flexible sensor based on nitrogen-doped graphene for selective determination of formononetin.
Chen, Y; Cui, F; Du, Y; Hu, F; Li, Y; Ma, J; Wei, H; Zhang-Peng, X, 2022
)
2.38
"Formononetin is a bioactive isoflavone that has numerous medicinal benefits. "( Formononetin regulates endothelial nitric oxide synthase to protect vascular endothelium in deep vein thrombosis rats.
Wang, X; Yan, M; Zhou, H; Zhou, Z; Zou, X,
)
3.02
"Formononetin is a natural isoflavonoid with potent neuroprotective activity but poor brain delivery."( Natural borneol enhances the anti-cerebral ischaemia efficacy of formononetin in MCAO/R rats by promoting its delivery in the brain.
Li, JY; Li, QH; Li, SS; Li, XF; Shen, XP; Shen, YH; Wang, JX; Xiao, JP; Zhang, WD, 2022
)
1.68
"Formononetin (FMN) is a methoxy isoflavone found abundantly in leguminous plants and associated foods. "( Development of an indirect competitive enzyme-linked immunosorbent assay for formononetin and its application in a cell-based assay using MC3T3-E1 cells.
Ehama, R; Fujii, S; Irikida, M; Nomura, S; Ohta, T; Shoyama, Y; Uto, T, 2023
)
2.58
"Formononetin (FMN) is a phytoestrogen that belongs to the isoflavone family. "( Formononetin improves the inflammatory response and bone destruction in knee joint lesions by regulating the NF-kB and MAPK signaling pathways.
Fang, JW; He, DW; Hu, XY; Lai, HH; Lou, C; Ni, KN; Pan, B; Pan, WZ; Yang, T; Ye, L; Zhang, YJ, 2023
)
3.8
"Formononetin is an active compound extracted from the herb"( Comparative transcriptomic analysis and mechanistic characterization revealed the use of formononetin for bladder cancer treatment.
Chen, J; Lai, KP; Qin, X; Wang, P; Zhang, X; Zhou, H, 2023
)
1.85
"Formononetin is a phytoestrogen which possess different pharmacological activities. "( Acute and sub-acute toxicity study reveals no dentrimental effect of formononetin in mice upon repeated
Gupta, GL; Pingale, TD, 2023
)
2.59
"Formononetin (FNT) is a plant-derived isoflavone natural product with anti-inflammatory, antioxidant, and anti-allergic properties. "( Formononetin Inhibits Mast Cell Degranulation to Ameliorate Compound 48/80-Induced Pseudoallergic Reactions.
Chen, JJ; Ji, K; Li, SY; Lin, SE; Zhou, ZW; Zhu, XY; Zhu, YH, 2023
)
3.8
"Formononetin is a flavonoid compound with anti-tumor and anti-inflammatory properties. "( Enhancing Anticancer Efficacy of Formononetin Microspheres via Microfluidic Fabrication.
Cao, X; Deng, T; Deng, W; Li, Q; Li, X; Liu, K; Liu, Q; Wang, Q; Weng, X; Xiao, G; Xu, X; Yu, J; Yu, Q, 2023
)
2.63
"Formononetin (FMN) is a natural isoflavone with numerous cardioprotective properties, which can inhibit the proliferation and induce the apoptosis of tumor cells; however, whether FMN has a therapeutic effect on PAH remains unclear."( Formononetin attenuates monocrotaline‑induced pulmonary arterial hypertension via inhibiting pulmonary vascular remodeling in rats.
Cai, C; Lin, W; Wu, Y; Xiang, Y; Xu, J; Zeng, C; Zhao, H; Zhu, N, 2019
)
2.68
"Formononetin is a natural isoflavone compound found mainly in Chinese herbal medicines such as astragalus and red clover. "( Formononetin, J1 and J2 have different effects on endothelial cells via EWSAT1-TRAF6 and its downstream pathway.
Chen, J; Huang, C; Huang, ZQ; Li, X; Liang, CM; Qi, GY; Ren, QY; Sui, CL, 2020
)
3.44
"Formononetin (FMN), which is a major bioactive isoflavone compound in Astragalus membranaceus, exerts anti-inflammatory effects and the promotion of myogenic differentiation."( Formononetin ameliorates muscle atrophy by regulating myostatin-mediated PI3K/Akt/FoxO3a pathway and satellite cell function in chronic kidney disease.
Cai, X; Hu, R; Huang, J; Li, J; Li, Q; Liu, L; Liu, Y; Wang, M; Wei, L; Wu, X; You, H, 2021
)
2.79
"Formononetin is a promising bioactive phytoestrogen with evident pharmacological properties. "( Bioinformatic and biochemical studies of formononetin against liver injure.
Huang, L; Li, T; Liao, L; Wei, X; Yin, L, 2021
)
2.33
"Formononetin (FMN) is a natural herb extract with multiple biological functions."( Formononetin protects against concanavalin-A-induced autoimmune hepatitis in mice through its anti-apoptotic and anti-inflammatory properties.
Bai, J; Cui, J; Liang, H; Liu, G; Lu, B; Zhao, W, 2021
)
2.79
"Formononetin (FORM) is an isoflavone from the group of phytoestrogens that exhibits a broad spectrum of physiological effects beneficial to health through dependent and independent mechanisms of estrogen. "( Formononetin: Biological effects and uses - A review.
Andrade Batista, R; Espitia, PJP; Machado Dutra, J, 2021
)
3.51
"Formononetin is a kind of isoflavone compound and has been reported to possess anti-inflammatory properties. "( Formononetin Administration Ameliorates Dextran Sulfate Sodium-Induced Acute Colitis by Inhibiting NLRP3 Inflammasome Signaling Pathway.
Deng, B; Ding, Y; Gong, W; Lu, G; Shan, Q; Wu, D; Wu, J; Wu, K; Xiao, W; Xue, Y; Yan, Z; Zhu, Q, 2018
)
3.37
"Formononetin is an isoflavone that is extracted from red clovers or soy. "( The O-methylated isoflavone, formononetin, inhibits human ovarian cancer cell proliferation by sub G0/G1 cell phase arrest through PI3K/AKT and ERK1/2 inactivation.
Bazer, FW; Lim, W; Park, S; Song, G, 2018
)
2.21
"Formononetin is a bioactive non-steroidal polyphenol found in a variety of plants. "( Formononetin inhibits neuroinflammation and increases estrogen receptor beta (ERβ) protein expression in BV2 microglia.
El-Bakoush, A; Olajide, OA, 2018
)
3.37
"Formononetin (FMN) is an isoflavone that produces arterial vasodilation. "( Formononetin induces vasorelaxation in rat thoracic aorta via regulation of the PI3K/PTEN/Akt signaling pathway.
Cui, H; Fan, R; Li, T; Luo, J; Tang, T; Wang, D; Wang, Y; Zhong, Y, 2018
)
3.37
"Formononetin is a polyphenolic compound reported for its effect on SIRT1 and ROS."( Formononetin attenuates kidney damage in type 2 diabetic rats.
Kulkarni, YA; Oza, MJ, 2019
)
2.68
"Formononetin is a potential molecule which increases the expression of SIRT1 in kidney tissue of diabetic. "( Formononetin attenuates kidney damage in type 2 diabetic rats.
Kulkarni, YA; Oza, MJ, 2019
)
3.4
"Formononetin is a naturally existing isoflavone, which can be found in the roots of Astragalus membranaceus, Trifolium pratense, Glycyrrhiza glabra, and Pueraria lobata. "( Formononetin inhibits migration and invasion of MDA-MB-231 and 4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through PI3K/AKT signaling pathways.
Chen, H; Du, H; Liao, M; Xu, L; Ye, M; Zhou, R, 2014
)
3.29
"Formononetin is a flavone with powerful antioxidant properties that exists naturally in various plants and Chinese medicine."( Formononetin attenuates hydrogen peroxide (H2O2)-induced apoptosis and NF-κB activation in RGC-5 cells.
Jia, WC; Liu, G; Zhang, CD; Zhang, SP, 2014
)
2.57
"Formononetin is an O-methylated isoflavone isolated from the root of Astragalus membranaceus. "( Formononetin promotes cell cycle arrest via downregulation of Akt/Cyclin D1/CDK4 in human prostate cancer cells.
Huang, W; Li, T; Ling, Z; Mo, Z; Yan, H; Ye, Y; Zhao, X, 2014
)
3.29
"Formononetin is an O-methylated isoflavone that is isolated from the root of Astragalus membranaceus, and it has antitumorigenic effects. "( Formononetin promotes proliferation that involves a feedback loop of microRNA-375 and estrogen receptor alpha in estrogen receptor-positive cells.
Chen, J; Huang, Z; Wang, Y; Ye, Y; Zhang, X, 2016
)
3.32
"Formononetin is a novel herbal isoflavonoid isolated from Astragalus membranaceus and possesses antitumorigenic properties. "( Formononetin suppresses the proliferation of human non-small cell lung cancer through induction of cell cycle arrest and apoptosis.
Ai, X; Cheng, B; Lu, S; Yang, Y; Zhao, Y, 2014
)
3.29
"Formononetin is a novel herbal isoflavonoid isolated from Astragalus membranaceus and possesses antitumorigenic properties."( Formononetin sensitizes glioma cells to doxorubicin through preventing EMT via inhibition of histone deacetylase 5.
Chen, HM; Chen, JK; Huang, HQ; Liu, Q; Sun, Y; Yan, XL; Zheng, JM, 2015
)
2.58
"Formononetin is an isoflavone that has been shown to display estrogenic properties and induce angiogenesis activities. "( Formononetin promotes angiogenesis through the estrogen receptor alpha-enhanced ROCK pathway.
Chan, SW; Dang, Y; Hoi, MP; Huang, B; Huang, X; Kwan, YW; Lee, SM; Leung, GP; Li, S; Zhang, Z; Zhou, X, 2015
)
3.3
"Formononetin is a novel herbal isoflavonoid isolated from Astragalus membranaceus, a medicinal plant that possesses antitumorigenic property. "( Novel herbal flavonoids promote apoptosis but differentially induce cell cycle arrest in human colon cancer cell.
Auyeung, KK; Ko, JK, 2010
)
1.8
"Formononetin (FMN) is a methoxylated isoflavone which is the major constituent in red clover and in commercially available extracts of this plant. "( PAMPA permeability, plasma protein binding, blood partition, pharmacokinetics and metabolism of formononetin, a methoxylated isoflavone.
Jain, GK; Pradhan, T; Singh, SP; Tewari, D, 2011
)
2.03
"Formononetin is a main active component of red clover plants (Trifolium pratense L.), and is considered as a phytoestrogen. "( Formononetin-induced apoptosis of human prostate cancer cells through ERK1/2 mitogen-activated protein kinase inactivation.
Chen, J; Hou, R; Huang, Y; Mo, L; Mo, Z; Ye, Y; Zhang, J, 2012
)
3.26
"Formononetin is a novel herbal isoflavonoid isolated from Astragalus membranaceus, a medicinal plant that possesses antitumorigenic properties. "( Novel anti-angiogenic effects of formononetin in human colon cancer cells and tumor xenograft.
Auyeung, KK; Ko, JK; Law, PC, 2012
)
2.1
"Formononetin (FMNT) is an isoflavone found in many herbs including Trifolium pratense L., Spatholobus suberectus Dunn., and Astragalus mongholicus Bunge. "( Neuroprotective effects of formononetin against NMDA-induced apoptosis in cortical neurons.
Li, XQ; Liu, SB; Tian, Z; Wang, YC; Zhao, MG; Zheng, LH, 2013
)
2.13
"Formononetin is an isoflavone with known estrogen-like activity."( Analysis of formononetin from black cohosh (Actaea racemosa).
Balick, MJ; Jiang, B; Kennelly, EJ; Kronenberg, F, 2006
)
1.43
"Formononetin is a phytoestrogen that exhibits variable degrees of estrogen receptor agonism in different test systems."( In vitro estrogenic activity of formononetin by two bioassay systems.
Choi, RC; Dong, TT; Ji, ZN; Liao, GR; Lo, CK; Tsim, KW; Zhao, WY, 2006
)
2.06
"Formononetin is an isoflavonoid phytoestrogen found in animal fodder and in certain human foodstuffs."( Proliferative response of mammary glandular tissue to formononetin.
Han, Z; Higuchi, CM; Tanaka, Y; Wang, W, 1995
)
1.26
"Formononetin is an isoflavonoid phytoestrogen found in animal fodder and in certain human foodstuffs. "( Radioimmunoassay determination of formononetin in murine plasma and mammary glandular tissue.
Wang, W, 1998
)
2.02

Effects

Formononetin (FMN) has been reported to protect against Alzheimer's disease (AD) and attenuates vascular inflammation in atherosclerosis. FMN has been shown to have protective effects against osteoporosis, but no previous study has evaluated the effects of FMN on wear particle-induced osteolysis.

ExcerptReferenceRelevance
"Formononetin has proven to be anti‑inflammatory and able to alleviate symptoms of certain allergic diseases. "( Formononetin ameliorates IL‑13‑induced inflammation and mucus formation in human nasal epithelial cells by activating the SIRT1/Nrf2 signaling pathway.
Chen, X; Huang, J; Xie, A, 2021
)
3.51
"Formononetin (FMN) has been reported to protect against Alzheimer's disease (AD) and attenuates vascular inflammation in atherosclerosis."( Formononetin attenuates Aβ
Fan, M; Hu, M; Jia, Y; Jin, W; Li, Z; Liu, Y; Song, J; Wang, S; Wang, T; Yang, R; Zhao, H, 2022
)
2.89
"Formononetin (FMN) has been reported as a prospective antiosteoporotic medication. "( Formononetin attenuates osteoclast differentiation and calcium loss by mediating transcription factor AP-1 in type I diabetic mice.
Feng, L; Jing, W; Peng, K; Wang, B; Zhang, W, 2022
)
3.61
"Formononetin has anti-inflammatory effects. "( Formononetin protects against inflammation associated with cerebral ischemia-reperfusion injury in rats by targeting the JAK2/STAT3 signaling pathway.
Chen, Q; He, Y; Wan, H; Yang, J; Yu, L; Zhang, Y; Zhou, H, 2022
)
3.61
"Formononetin (FMN) has been shown to have protective effects against osteoporosis, but no previous study has evaluated the effects of FMN on wear particle-induced osteolysis."( Inhibitory effects of Formononetin on CoCrMo particle-induced osteoclast activation and bone loss through downregulating NF-κB and MAPK signaling.
Chen, B; Ding, C; Ding, H; Liu, Y; Ren, Z; Sun, Z; Wang, D; Wu, Q; Yang, B; Yu, X; Yuan, T; Zhang, L; Zhao, J, 2023
)
1.95
"Formononetin has been proven to exhibit various pharmacological effects including anti-tumor, anti-obesity, anti-inflammation, and neuroprotective effects."( Anti-cancer targets and molecular mechanisms of formononetin in treating osteosarcoma based on network pharmacology.
Chen, L; Huang, W; Li, T; Liu, H; Liu, S; Wang, Y; Weng, Z; Yang, Y; Zhou, Y, 2023
)
1.89
"Formononetin has been reported to ameliorate hyperlipidemia and obesity, but its effect and mechanism of action in anti-non-alcoholic fatty liver disease (NAFLD) remain unclear. "( Formononetin alleviates hepatic steatosis by facilitating TFEB-mediated lysosome biogenesis and lipophagy.
Li, P; Li, X; Peng, L; Wang, Q; Wang, Y; Yan, M; Zhang, H; Zhang, N; Zhang, P; Zhao, H; Zhao, T, 2019
)
3.4
"Formononetin has shown a variety of pharmacologic properties including anti-inflammatory effect. "( Formononetin inhibited the inflammation of LPS-induced acute lung injury in mice associated with induction of PPAR gamma expression.
Fu, Q; Ji, W; Ma, S; Ma, Z, 2013
)
3.28
"Formononetin has inhibitory effects on the proliferation of U2SO cells, both in vitro and in vivo. "( Formononetin induces apoptosis of human osteosarcoma cell line U2OS by regulating the expression of Bcl-2, Bax and MiR-375 in vitro and in vivo.
Hu, W; Xiao, Z, 2015
)
3.3

Actions

Formononetin effectively plays a significant role in inhibiting cell proliferation, invasion, and metastatic abilities of cancer cells. It could inhibit EV71-induced COX-2 expression and PGE₂ production via MAPKs pathway including ERK, p38 and JNK.

ExcerptReferenceRelevance
"Formononetin promotes cell survival and proliferation, and prevents apoptosis in a concentration-dependent manner."( Formononetin ameliorates the LPS-induced inflammatory response and apoptosis of neuronal cells via NF-κB/NLRP3 signaling pathway.
Zhang, P; Zhou, Z, 2023
)
3.07
"Formononetin effectively plays a significant role in inhibiting cell proliferation, invasion, and metastatic abilities of cancer cells by targeting major signaling pathways at the junction of interconnected pathways."( The potential role of formononetin in cancer treatment: An updated review.
Alhammadi, M; Aliya, S; Han, YK; Huh, YS; Lee, JH; Park, U; Tiwari, JN, 2023
)
1.95
"Formononetin could inhibit EV71-induced COX-2 expression and PGE₂ production via MAPKs pathway including ERK, p38 and JNK. "( Formononetin inhibits enterovirus 71 replication by regulating COX- 2/PGE₂ expression.
Ge, M; Jiang, J; Li, Y; Li, Z; Wang, H; Zhang, D, 2015
)
3.3
"Formononetin increase the uterus coefficient and the expression of atrial ERbeta (P < 0.01), but it dose not have any effect on the expression of ERalpha (P > 0.05)."( [The estrogenic effect of formononetin and its effect on the expression of rats' atrium estrogen receptors].
Huang, Q; Liu, XL; Liu, ZG; Xing, DX; Xiong, L; Xue, CK, 2010
)
1.38

Treatment

Formononetin treatment significantly ameliorated hepatic steatosis in HFD mice. Treatment for 16 week was able to control hyperglycemia and insulin resistance in diabetic animals.

ExcerptReferenceRelevance
"Formononetin treatment was shown to inhibit the proliferation of eutopic and ectopic endometria in patients with endometriosis through the regulation of p27, pSTAT3, and PR-B. "( Formononetin Inhibits Progression of Endometriosis via Regulation of p27, pSTAT3, and Progesterone Receptor: In Vitro and In Vivo Studies.
Cho, S; Choi, YS; Choo, SP; Im, W; Jung, GS; Kim, S; Lee, I; Lee, JH; Lee, MJ; Park, H; Park, Y, 2023
)
3.8
"Formononetin treatment significantly ameliorated hepatic steatosis in HFD mice."( Formononetin alleviates hepatic steatosis by facilitating TFEB-mediated lysosome biogenesis and lipophagy.
Li, P; Li, X; Peng, L; Wang, Q; Wang, Y; Yan, M; Zhang, H; Zhang, N; Zhang, P; Zhao, H; Zhao, T, 2019
)
2.68
"Formononetin pretreatment notably attenuated hyperoxia-induced elevating pulmonary water content, upregulation of proinflammatory cytokine levels and increasing infiltration of neutrophil in the lung. "( Reduction of hyperoxic acute lung injury in mice by Formononetin.
Chen, J; Chen, Y; Wei, D; Xu, X; Zhao, J, 2021
)
2.31
"Formononetin pretreatment reduces hyperoxia-induced ALI via Nrf2/HO-1-mediated antioxidant and anti-inflammatory effects."( Reduction of hyperoxic acute lung injury in mice by Formononetin.
Chen, J; Chen, Y; Wei, D; Xu, X; Zhao, J, 2021
)
2.31
"Formononetin treatment also led to predominant runt-related transcription factor 2 and osteocalcin localisation at the injury site."( Formononetin, a methoxy isoflavone, enhances bone regeneration in a mouse model of cortical bone defect.
Dev, K; Dixit, M; Maurya, R; Singh, D; Singh, KB, 2017
)
2.62
"Formononetin treatment for 16 week was able to control hyperglycemia and insulin resistance in diabetic animals. "( Formononetin attenuates kidney damage in type 2 diabetic rats.
Kulkarni, YA; Oza, MJ, 2019
)
3.4
"Formononetin treatment also reduced circulating vascular adhesion cell molecule-1 (P<0.01)."( Isoflavones reduce arterial stiffness: a placebo-controlled study in men and postmenopausal women.
Cehun, M; DeSilva, L; Fassoulakis, A; McGrath, BP; Nestel, PJ; Teede, HJ, 2003
)
1.04
"Treatment with formononetin promoted lysosome biogenesis and autophagosome-lysosome fusion, relieving the blockade in autophagic flux and further induced lipophagy."( Formononetin alleviates hepatic steatosis by facilitating TFEB-mediated lysosome biogenesis and lipophagy.
Li, P; Li, X; Peng, L; Wang, Q; Wang, Y; Yan, M; Zhang, H; Zhang, N; Zhang, P; Zhao, H; Zhao, T, 2019
)
2.3
"Treatment with formononetin commenced the day after and continued for 21 d."( Formononetin, a methoxy isoflavone, enhances bone regeneration in a mouse model of cortical bone defect.
Dev, K; Dixit, M; Maurya, R; Singh, D; Singh, KB, 2017
)
2.24
"Co-treatment of formononetin with pharmacological inhibitors (LY294002 or U0126) revealed additional anti-proliferative effects on the two human ovarian cancer cell types."( The O-methylated isoflavone, formononetin, inhibits human ovarian cancer cell proliferation by sub G0/G1 cell phase arrest through PI3K/AKT and ERK1/2 inactivation.
Bazer, FW; Lim, W; Park, S; Song, G, 2018
)
1.11
"Treatment of formononetin was started after confirmation of diabetes and continued for 16 weeks."( Formononetin attenuates kidney damage in type 2 diabetic rats.
Kulkarni, YA; Oza, MJ, 2019
)
2.31
"Pretreatment with formononetin noncompetitively inhibited contractile responses of aortas to NE and KCl."( Vasorelaxant effect of formononetin in the rat thoracic aorta and its mechanisms.
Chen, BN; Du, GH; Wang, SB; Wang, SH; Zhao, Y, 2012
)
1.01

Toxicity

ExcerptReferenceRelevance
" Among various adverse effects of PIs, hepatotoxicity is a very common adverse reaction of RIT which is concentration dependent."( Formononetin and biochanin A protects against ritonavir induced hepatotoxicity via modulation of NfκB/pAkt signaling molecules.
Agarwal, NK; Azmi, L; Chaturvedi, S; Malik, MY; Naseem, Z; Rao, C; Shukla, I, 2018
)
1.92
"Five groups of animals were subjected to treatment as control, toxic control (RIT), third group (RIT + FMN), fourth group (RIT + BCA), the fifth group (RIT + FMN + BCA) and sixth group (FMN + BCA) for 14 days."( Formononetin and biochanin A protects against ritonavir induced hepatotoxicity via modulation of NfκB/pAkt signaling molecules.
Agarwal, NK; Azmi, L; Chaturvedi, S; Malik, MY; Naseem, Z; Rao, C; Shukla, I, 2018
)
1.92

Pharmacokinetics

A sensitive, accuracy and suitable LC-MS/MS method for determination of formononetin, calycosin and isorhamnetin is developed. It was successfully applied to the pharmacokinetic study of 10 g/kg Astragalus mongholicus after oral administration in rats.

ExcerptReferenceRelevance
"Isoflavones have pharmacokinetic characteristics that suggest that once-daily administration is adequate when they are administered long-term as dietary supplements."( Long-term pharmacokinetics of an extract of isoflavones from red clover (Trifolium pratense).
Howes, J; Howes, LG; Huang, L; Waring, M, 2002
)
0.31
" The permeability study samples were analyzed by HPLC-PDA method; whereas the pharmacokinetic study, protein binding and whole blood partitioning samples were analyzed by LC-MS/MS method."( PAMPA permeability, plasma protein binding, blood partition, pharmacokinetics and metabolism of formononetin, a methoxylated isoflavone.
Jain, GK; Pradhan, T; Singh, SP; Tewari, D, 2011
)
0.59
" The method was applied to a comparative pharmacokinetic study after administration of Yu Ping Feng San to rats at different doses (10, 20 and 40g/kg)."( Development of an SPE-HPLC-MS method for simultaneous determination and pharmacokinetic study of bioactive constituents of Yu Ping Feng San in rat plasma after oral administration.
Chen, L; Li, T; Liang, R; Wang, Y; Yang, W; Zhang, D; Zhang, H, 2013
)
0.39
" The rapid and sensitive method was fully validated and successfully applied to the pharmacokinetic study of formononetin, cryptotanshinone, tanshinone IIA and emodin in rats following oral administration of Bu Shen Huo Xue formula."( A rapid UFLC-MS/MS method for simultaneous determination of formononetin, cryptotanshinone, tanshinone IIA and emodin in rat plasma and its application to a pharmacokinetic study of Bu Shen Huo Xue formula.
Huang, K; Pan, Y; Ren, Y; Wang, X; Xiang, Z; Xu, Y; Yan, P, 2013
)
0.84
"To establish a method to determine the concentration of formononetin, calycosin and isorhamnetin from Astragalus mongholicus in rats' plasma using LC-MS/MS and calculate their pharmacokinetic parameters."( [Simultaneous determination of formononetin, calycosin and isorhamnetin from Astragalus mongholicus in rat plasma by LC-MS/MS and application to pharmacokinetic study].
Li, Y; Lin, Q; Tan, XM; Yao, XC, 2013
)
0.92
" The pharmacokinetic parameter, t(1/2beta), of formononetin, calycosin and isorhamnetin was (10."( [Simultaneous determination of formononetin, calycosin and isorhamnetin from Astragalus mongholicus in rat plasma by LC-MS/MS and application to pharmacokinetic study].
Li, Y; Lin, Q; Tan, XM; Yao, XC, 2013
)
0.93
"A sensitive, accuracy and suitable LC-MS/MS method for determination of formononetin, calycosin and isorhamnetin is developed and successfully applied to the pharmacokinetic study of 10 g/kg Astragalus mongholicus after oral administration in rats."( [Simultaneous determination of formononetin, calycosin and isorhamnetin from Astragalus mongholicus in rat plasma by LC-MS/MS and application to pharmacokinetic study].
Li, Y; Lin, Q; Tan, XM; Yao, XC, 2013
)
0.91
" This method was successfully applied to the pharmacokinetic study of the five compounds in rats after oral administration of Shenqi Wuwei chewable tablets."( Simultaneous determination of calycosin-7-O-β-d-glucoside, calycosin, formononetin, astragaloside IV and schisandrin in rat plasma by LC-MS/MS: application to a pharmacokinetic study after oral administration of Shenqi Wuwei chewable tablets.
An, Y; Shi, G; Sun, X; Wu, Q; Wu, X; Zhang, M; Zhang, P, 2014
)
0.64
" This developed method was applied subsequently to pharmacokinetic studies of the six compounds in rats successfully."( Simultaneous determination of calycosin-7-O-β-D-glucoside, ononin, calycosin, formononetin, astragaloside IV, and astragaloside II in rat plasma after oral administration of Radix Astragali extraction for their pharmacokinetic studies by ultra-pressure li
Feng, SL; Guo, L; Hu, F; Liu, XH; Yang, YL; Zhao, JB; Zhu, RJ, 2014
)
0.63
" The developed method was successfully applied to a pharmacokinetic study of linarin, naringenin and formononetin in rats after oral administration of Bushen Guchi Pill."( Simultaneous determination of linarin, naringenin and formononetin in rat plasma by LC-MS/MS and its application to a pharmacokinetic study after oral administration of Bushen Guchi Pill.
Dong, L; Guo, P; Wang, C; Wei, J; Yan, W; Zhang, Z, 2015
)
0.88
"2% to 112%, which demonstrated that the LC-MS/MS method could be used to evaluate the pharmacokinetic feature of the six compounds in rats after oral administration of DLT."( A network pharmacology integrated pharmacokinetics strategy for uncovering pharmacological mechanism of compounds absorbed into the blood of Dan-Lou tablet on coronary heart disease.
Chang, YX; Chen, S; Ding, M; Gao, XM; Li, J; Li, Y; Ma, W; Mao, H; Wang, H; Wang, Q; Wang, X; Wei, J; Yang, X; Yang, Y; Zou, S, 2019
)
0.51

Compound-Compound Interactions

ExcerptReferenceRelevance
"A dynamic microdialysis sampling method with liquid chromatography-diode array detection and time-of-flight mass spectrometry (LC-DAD-TOF/MS) analysis was developed to investigate rat microsomal metabolisms of calycosin and formononetin, and their drug-drug interactions."( Microsomal metabolism of calycosin, formononetin and drug-drug interactions by dynamic microdialysis sampling and HPLC-DAD-MS analysis.
Li, B; Li, P; Liu, EH; Qi, LW; Wang, YQ; Wen, XD; Yang, XL; Yi, L, 2009
)
0.81
"The crude methanol extract of Pueraria lobata was investigated by dual high-resolution α-glucosidase inhibition and radical scavenging profiling combined with hyphenated HPLC-HRMS-SPE-NMR."( Dual high-resolution α-glucosidase and radical scavenging profiling combined with HPLC-HRMS-SPE-NMR for identification of minor and major constituents directly from the crude extract of Pueraria lobata.
Jäger, AK; Kongstad, KT; Liu, B; Nyberg, NT; Qinglei, S; Staerk, D, 2015
)
0.42
" The results indicate that potential drug-drug interactions might exist when the tested drugs, specifically HQ, are co-administered with other substrate drugs that are metabolized or transported via the studied DMEs or ETs."( Regulation of drug-metabolizing enzymes and efflux transporters by Astragali radix decoction and its main bioactive compounds: Implication for clinical drug-drug interactions.
Li, F; Liu, Y; Liu, Z; Lu, L; Ou, R; Tong, Y; Wu, J; Zhang, G; Zheng, L, 2016
)
0.43
" Our findings suggest that biospecific live cell-based isolation combined with SPE and HPLC-MS/MS is an effective method for screening potential bioactive components in traditional Chinese medicines."( Biospecific isolation and characterization of angiogenesis-promoting ingredients in Buyang Huanwu decoction using affinity chromatography on rat brain microvascular endothelial cells combined with solid-phase extraction, and HPLC-MS/MS.
He, D; Liao, F; Meng, Y; Shen, X; Wang, L; Wu, Y; Yu, J; Zheng, H, 2018
)
0.48

Bioavailability

Formononetin and ononin were 21% oral bioavailability. Supplementation with FOS led to a significant decrease in the bioavailability of daidzein. Cladrin had much better plasma bioavailability compared with formonetin.

ExcerptReferenceRelevance
" MRP type efflux pumps may limit the bioavailability of EGCG."( Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites.
Hong, J; Lambert, JD; Lee, SH; Sinko, PJ; Yang, CS, 2003
)
0.32
" Cladrin had much better plasma bioavailability compared with formononetin."( Differential effects of formononetin and cladrin on osteoblast function, peak bone mass achievement and bioavailability in rats.
Bhargavan, B; Chattopadhyay, N; Gautam, AK; Jain, GK; Kumar, M; Manickavasagam, L; Maurya, R; Mishra, JS; Sanyal, S; Singh, A; Singh, AB; Singh, D; Singh, SP; Srivastava, K; Tyagi, AM; Wahajuddin, W; Yadav, DK, 2011
)
0.92
" The experimental results showed that the qulaity concentration of formononetin in the perfusate had no significant effect on the absorption rate constant (K(a)) and the apparent absorption coefficient (P(app)); K(a) and P(app) of formononetin in duodenum, jejunum and ileum showed no significant difference."( [Study on intestinal absorption of formononetin in Millettia nitita var. hirsutissima in rats].
Liu, YL; Song, YG; Su, D; Xiong, XB; Yang, SL; Zhang, L, 2013
)
0.9
" Bioavailability and metabolism of these red clover isoflavones (RCI) have not been studied in detail."( Red clover isoflavone metabolite bioavailability is decreased after fructooligosaccharide supplementation.
Chedraui, P; Hobiger, S; Imhof, M; Jungbauer, A; Laschitz, T; Lipovac, M; Pfitscher, A, 2015
)
0.42
"To determine the bioavailability of RCI metabolites and analyse whether FOS supplementation could influence their bioavailability."( Red clover isoflavone metabolite bioavailability is decreased after fructooligosaccharide supplementation.
Chedraui, P; Hobiger, S; Imhof, M; Jungbauer, A; Laschitz, T; Lipovac, M; Pfitscher, A, 2015
)
0.42
" In the first, compound bioavailability was determined after consumption of 80 mg of RCI (MF11RCE)."( Red clover isoflavone metabolite bioavailability is decreased after fructooligosaccharide supplementation.
Chedraui, P; Hobiger, S; Imhof, M; Jungbauer, A; Laschitz, T; Lipovac, M; Pfitscher, A, 2015
)
0.42
" Supplementation with FOS led to a significant decrease in the bioavailability of daidzein, dihydroformononetin, dihydrogenistein and dihydrodaidzein."( Red clover isoflavone metabolite bioavailability is decreased after fructooligosaccharide supplementation.
Chedraui, P; Hobiger, S; Imhof, M; Jungbauer, A; Laschitz, T; Lipovac, M; Pfitscher, A, 2015
)
0.63
"This study is the first to provide detailed data on RCI bioavailability in humans and determine no influence of FOS yet a trend toward increased equol production."( Red clover isoflavone metabolite bioavailability is decreased after fructooligosaccharide supplementation.
Chedraui, P; Hobiger, S; Imhof, M; Jungbauer, A; Laschitz, T; Lipovac, M; Pfitscher, A, 2015
)
0.42
" Widely used soy is a source of poorly absorbed isoflavones glycosides."( Evaluation of estrogenic activity of red clover (Trifolium pratense L.) sprouts cultivated under different conditions by content of isoflavones, calorimetric study and molecular modelling.
Brzozowska, E; Budryn, G; Cerón-Carrasco, JP; Gałązka-Czarnecka, I; Grzelczyk, J; Mostowski, R; Pérez-Sánchez, H; Żyżelewicz, D, 2018
)
0.48
" The oral bioavailability of formononetin and ononin were 21."( Pharmacokinetics and Bioavailability of the Isoflavones Formononetin and Ononin and Their in Vitro Absorption in Ussing Chamber and Caco-2 Cell Models.
Fan, MX; Gao, WY; Li, MX; Luo, LY; Wu, X; Zhao, HY, 2018
)
1.02
" Recently, superfine pulverizing technology has been applied to developing novel formulations to improve bioavailability of the active constituents in herbs, such as ultrafine granular powder of AR."( Comparative pharmacokinetic study on three formulations of Astragali Radix by an LC-MS/MS method for determination of formononetin in human plasma.
Gong, YF; He, K; Lv, LZ; Peng, JB; Rao, T; Tan, ZR; Wang, YC; Zhou, HH, 2019
)
0.72
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
"Improving solubility and administration route of isoflavone formononetin (FMN) are critical factors to improve its bioavailability in the oral cavity."( Formononetin/methyl-β-cyclodextrin inclusion complex incorporated into electrospun polyvinyl-alcohol nanofibers: Enhanced water solubility and oral fast-dissolving property.
Deng, Z; Fang, S; Liang, X; Lu, Y; Shi, Y; Wang, X; Wang, Y, 2021
)
2.31
" Moreover, synergistic effect with anticancer drugs and methods to improve bioavailability are explained."( Potential Therapeutic Targets of Formononetin, a Type of Methoxylated Isoflavone, and Its Role in Cancer Therapy through the Modulation of Signal Transduction Pathways.
Almatroodi, SA; Almatroudi, A; Khan, AA; Rahmani, AH, 2023
)
1.19

Dosage Studied

ExcerptRelevanceReference
"Trough plasma levels were significantly higher for daidzein and genistein after long-term dosing than levels taken prior to the commencement of the study and plasma levels of isoflavones after long-term dosing were in the range previously reported in populations that consume an isoflavone-rich diet."( Long-term pharmacokinetics of an extract of isoflavones from red clover (Trifolium pratense).
Howes, J; Howes, LG; Huang, L; Waring, M, 2002
)
0.31
" At a dosage of 250 microg/pellet the red clover extract showed excellent inhibition of angiogenesis."( Inhibition of angiogenesis and inflammation by an extract of red clover (Trifolium pratense L.).
Krenn, L; Paper, DH, 2009
)
0.35
" Isoformo at the concentration reaching the bone marrow achieved out of its most effective oral dosing induced stromal cell mineralization and osteogenic gene expression in the calvaria of neonatal rats."( Isoformononetin, a methoxydaidzein present in medicinal plants, reverses bone loss in osteopenic rats and exerts bone anabolic action by preventing osteoblast apoptosis.
Changkija, B; Chattopadhyay, N; Dixit, M; Jain, GK; Khan, K; Khan, MP; Kumar, A; Lahiri, S; Maurya, R; Nagar, GK; Singh, D; Singh, SP; Srivastava, K; Trivedi, R; Tyagi, AM; Yadav, DK, 2013
)
1.01
" This study aimed to investigate how FMNT can reshape the gut microbiota at a specific dosage and ameliorate the symptoms of obesity-related metabolic disorders in both genders."( Formononetin reshapes the gut microbiota, prevents progression of obesity and improves host metabolism.
Naudhani, M; Ni, ZJ; Thakur, K; Wei, ZJ; Zhang, JG, 2021
)
2.06
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
phytoestrogenAny compound produced by a plant that happens to have estrogenic activity.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
7-hydroxyisoflavonesA hydroxyisoflavone compound having a hydroxy group at the 7-position.
4'-methoxyisoflavonesAny methoxyisoflavone which has a methoxy group at the 4-position of the phenyl substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (10)

PathwayProteinsCompounds
(-)-maackiain biosynthesis016
superpathway of pterocarpan biosynthesis (via formononetin)031
(-)-medicarpin biosynthesis010
superpathway of formononetin derivative biosynthesis031
formononetin conjugates interconversion014
rot-2'-enonate biosynthesis010
formononetin biosynthesis011
(-)-maackiain biosynthesis217
formononetin conjugates interconversion016
(-)-medicarpin biosynthesis210
rot-2'-enonate biosynthesis012
superpathway of pterocarpan biosynthesis (via formononetin)334
superpathway of formononetin derivative biosynthesis234
Maackiain biosynthesis06
Medicarpin biosynthesis012
Pterocarpan biosynthesis07

Protein Targets (80)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, HADH2 proteinHomo sapiens (human)Potency37.08140.025120.237639.8107AID886; AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency37.08140.025120.237639.8107AID886; AID893
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency29.90330.177814.390939.8107AID2147
LuciferasePhotinus pyralis (common eastern firefly)Potency2.00050.007215.758889.3584AID1224835
BRCA1Homo sapiens (human)Potency2.23870.89137.722525.1189AID624202
RAR-related orphan receptor gammaMus musculus (house mouse)Potency0.51480.006038.004119,952.5996AID1159521; AID1159523
GLS proteinHomo sapiens (human)Potency31.62280.35487.935539.8107AID624170
GLI family zinc finger 3Homo sapiens (human)Potency7.97290.000714.592883.7951AID1259368; AID1259369; AID1259392
Microtubule-associated protein tauHomo sapiens (human)Potency5.01190.180013.557439.8107AID1460
AR proteinHomo sapiens (human)Potency10.78240.000221.22318,912.5098AID1259243; AID1259247; AID1259381; AID743035; AID743036; AID743040; AID743042; AID743054
caspase 7, apoptosis-related cysteine proteaseHomo sapiens (human)Potency4.32770.013326.981070.7614AID1346978
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency39.81070.011212.4002100.0000AID1030
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency2.73060.000657.913322,387.1992AID1259377
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency3.10380.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency21.68990.000417.946075.1148AID1346795
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency0.43640.000214.376460.0339AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency0.52510.003041.611522,387.1992AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency8.70760.000817.505159.3239AID1159527
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency10.63340.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
pregnane X nuclear receptorHomo sapiens (human)Potency1.36850.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency4.64590.000229.305416,493.5996AID1259244; AID1259248; AID1259383; AID743069; AID743075; AID743077; AID743079; AID743080; AID743091
caspase-3Homo sapiens (human)Potency4.32770.013326.981070.7614AID1346978
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)Homo sapiens (human)Potency12.58930.016525.307841.3999AID602332
aryl hydrocarbon receptorHomo sapiens (human)Potency5.95240.000723.06741,258.9301AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency0.54480.001723.839378.1014AID743083
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency61.644819.739145.978464.9432AID1159509
cytochrome P450 2D6 isoform 1Homo sapiens (human)Potency10.00000.00207.533739.8107AID891
cellular tumor antigen p53 isoform aHomo sapiens (human)Potency9.31590.316212.443531.6228AID902; AID924
cytochrome P450 2C19 precursorHomo sapiens (human)Potency7.94330.00255.840031.6228AID899
cytochrome P450 2C9 precursorHomo sapiens (human)Potency0.01000.00636.904339.8107AID883
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency30.30010.001815.663839.8107AID894
nuclear factor erythroid 2-related factor 2 isoform 2Homo sapiens (human)Potency16.36010.00419.984825.9290AID504444
parathyroid hormone/parathyroid hormone-related peptide receptor precursorHomo sapiens (human)Potency112.20203.548119.542744.6684AID743266
histone deacetylase 9 isoform 3Homo sapiens (human)Potency2.55380.037617.082361.1927AID1259364; AID1259388
importin subunit beta-1 isoform 1Homo sapiens (human)Potency7.30785.804836.130665.1308AID540253
snurportin-1Homo sapiens (human)Potency7.30785.804836.130665.1308AID540253
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency22.55510.000627.21521,122.0200AID743202; AID743219
GTP-binding nuclear protein Ran isoform 1Homo sapiens (human)Potency7.30785.804816.996225.9290AID540253
urokinase-type plasminogen activator precursorMus musculus (house mouse)Potency5.01190.15855.287912.5893AID540303
plasminogen precursorMus musculus (house mouse)Potency5.01190.15855.287912.5893AID540303
urokinase plasminogen activator surface receptor precursorMus musculus (house mouse)Potency5.01190.15855.287912.5893AID540303
survival motor neuron protein isoform dHomo sapiens (human)Potency11.22020.125912.234435.4813AID1458
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency15.84890.031610.279239.8107AID884; AID885
lethal factor (plasmid)Bacillus anthracis str. A2012Potency12.58930.020010.786931.6228AID912
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency0.86350.001557.789015,848.9004AID1259244
Cellular tumor antigen p53Homo sapiens (human)Potency27.30600.002319.595674.0614AID651631
Integrin beta-3Homo sapiens (human)Potency8.71690.316211.415731.6228AID924
Integrin alpha-IIbHomo sapiens (human)Potency8.71690.316211.415731.6228AID924
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency0.86350.001551.739315,848.9004AID1259244
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Histamine H2 receptorCavia porcellus (domestic guinea pig)Potency0.01000.00638.235039.8107AID883
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency2.12590.011917.942071.5630AID651632; AID720516
Ataxin-2Homo sapiens (human)Potency1.72290.011912.222168.7989AID651632
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Neuraminidase Influenza A virus (A/Wilson-Smith/1933(H1N1))IC50 (µMol)44.92710.00000.503510.0000AID1073042; AID1073043; AID1073044; AID1073045; AID366284; AID366285; AID366286
Cytochrome P450 1A1Homo sapiens (human)IC50 (µMol)100.00000.00791.24789.9000AID266705
Urease subunit alphaHelicobacter pylori 26695IC50 (µMol)2,003.00000.29003.87606.7000AID745311
Amine oxidase [flavin-containing] AHomo sapiens (human)IC50 (µMol)31.20000.00002.37899.7700AID1632838
Amine oxidase [flavin-containing] BHomo sapiens (human)IC50 (µMol)25.80000.00001.89149.5700AID1632839
Proteasome subunit beta type-5Homo sapiens (human)IC50 (µMol)100.00000.00050.939410.0000AID1633148
Substance-P receptorCavia porcellus (domestic guinea pig)IC50 (µMol)100.00000.00002.751810.0000AID366285
Urease subunit betaHelicobacter pylori 26695IC50 (µMol)2,003.00000.29003.87606.7000AID745311
Substance-K receptorCavia porcellus (domestic guinea pig)IC50 (µMol)100.00000.01500.01500.0150AID366285
Amine oxidase [flavin-containing] AMus musculus (house mouse)IC50 (µMol)21.20000.00004.85008.0000AID1632845
Amine oxidase [flavin-containing] BMus musculus (house mouse)IC50 (µMol)11.00000.00001.50673.9200AID1632846
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Interleukin-2Homo sapiens (human)Kd5.47000.00001.30375.4700AID1156797
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (297)

Processvia Protein(s)Taxonomy
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cellular response to organic cyclic compoundCytochrome P450 1A1Homo sapiens (human)
response to hypoxiaCytochrome P450 1A1Homo sapiens (human)
long-chain fatty acid metabolic processCytochrome P450 1A1Homo sapiens (human)
lipid hydroxylationCytochrome P450 1A1Homo sapiens (human)
fatty acid metabolic processCytochrome P450 1A1Homo sapiens (human)
steroid biosynthetic processCytochrome P450 1A1Homo sapiens (human)
porphyrin-containing compound metabolic processCytochrome P450 1A1Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1A1Homo sapiens (human)
steroid metabolic processCytochrome P450 1A1Homo sapiens (human)
estrogen metabolic processCytochrome P450 1A1Homo sapiens (human)
amine metabolic processCytochrome P450 1A1Homo sapiens (human)
response to nematodeCytochrome P450 1A1Homo sapiens (human)
response to herbicideCytochrome P450 1A1Homo sapiens (human)
ethylene metabolic processCytochrome P450 1A1Homo sapiens (human)
coumarin metabolic processCytochrome P450 1A1Homo sapiens (human)
flavonoid metabolic processCytochrome P450 1A1Homo sapiens (human)
response to iron(III) ionCytochrome P450 1A1Homo sapiens (human)
insecticide metabolic processCytochrome P450 1A1Homo sapiens (human)
dibenzo-p-dioxin catabolic processCytochrome P450 1A1Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1A1Homo sapiens (human)
response to foodCytochrome P450 1A1Homo sapiens (human)
response to lipopolysaccharideCytochrome P450 1A1Homo sapiens (human)
response to vitamin ACytochrome P450 1A1Homo sapiens (human)
response to immobilization stressCytochrome P450 1A1Homo sapiens (human)
vitamin D metabolic processCytochrome P450 1A1Homo sapiens (human)
retinol metabolic processCytochrome P450 1A1Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 1A1Homo sapiens (human)
9-cis-retinoic acid biosynthetic processCytochrome P450 1A1Homo sapiens (human)
camera-type eye developmentCytochrome P450 1A1Homo sapiens (human)
nitric oxide metabolic processCytochrome P450 1A1Homo sapiens (human)
response to arsenic-containing substanceCytochrome P450 1A1Homo sapiens (human)
digestive tract developmentCytochrome P450 1A1Homo sapiens (human)
tissue remodelingCytochrome P450 1A1Homo sapiens (human)
hydrogen peroxide biosynthetic processCytochrome P450 1A1Homo sapiens (human)
response to hyperoxiaCytochrome P450 1A1Homo sapiens (human)
maternal process involved in parturitionCytochrome P450 1A1Homo sapiens (human)
hepatocyte differentiationCytochrome P450 1A1Homo sapiens (human)
cellular response to copper ionCytochrome P450 1A1Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1A1Homo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleCytochrome P450 1A1Homo sapiens (human)
response to 3-methylcholanthreneCytochrome P450 1A1Homo sapiens (human)
negative regulation of low-density lipoprotein receptor activityIntegrin beta-3Homo sapiens (human)
positive regulation of protein phosphorylationIntegrin beta-3Homo sapiens (human)
positive regulation of endothelial cell proliferationIntegrin beta-3Homo sapiens (human)
positive regulation of cell-matrix adhesionIntegrin beta-3Homo sapiens (human)
cell-substrate junction assemblyIntegrin beta-3Homo sapiens (human)
cell adhesionIntegrin beta-3Homo sapiens (human)
cell-matrix adhesionIntegrin beta-3Homo sapiens (human)
integrin-mediated signaling pathwayIntegrin beta-3Homo sapiens (human)
embryo implantationIntegrin beta-3Homo sapiens (human)
blood coagulationIntegrin beta-3Homo sapiens (human)
positive regulation of endothelial cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of gene expressionIntegrin beta-3Homo sapiens (human)
negative regulation of macrophage derived foam cell differentiationIntegrin beta-3Homo sapiens (human)
positive regulation of fibroblast migrationIntegrin beta-3Homo sapiens (human)
negative regulation of lipid storageIntegrin beta-3Homo sapiens (human)
response to activityIntegrin beta-3Homo sapiens (human)
smooth muscle cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of smooth muscle cell migrationIntegrin beta-3Homo sapiens (human)
platelet activationIntegrin beta-3Homo sapiens (human)
positive regulation of vascular endothelial growth factor receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
cell-substrate adhesionIntegrin beta-3Homo sapiens (human)
activation of protein kinase activityIntegrin beta-3Homo sapiens (human)
negative regulation of lipid transportIntegrin beta-3Homo sapiens (human)
regulation of protein localizationIntegrin beta-3Homo sapiens (human)
regulation of actin cytoskeleton organizationIntegrin beta-3Homo sapiens (human)
cell adhesion mediated by integrinIntegrin beta-3Homo sapiens (human)
positive regulation of cell adhesion mediated by integrinIntegrin beta-3Homo sapiens (human)
positive regulation of osteoblast proliferationIntegrin beta-3Homo sapiens (human)
heterotypic cell-cell adhesionIntegrin beta-3Homo sapiens (human)
substrate adhesion-dependent cell spreadingIntegrin beta-3Homo sapiens (human)
tube developmentIntegrin beta-3Homo sapiens (human)
wound healing, spreading of epidermal cellsIntegrin beta-3Homo sapiens (human)
cellular response to platelet-derived growth factor stimulusIntegrin beta-3Homo sapiens (human)
apolipoprotein A-I-mediated signaling pathwayIntegrin beta-3Homo sapiens (human)
wound healingIntegrin beta-3Homo sapiens (human)
apoptotic cell clearanceIntegrin beta-3Homo sapiens (human)
regulation of bone resorptionIntegrin beta-3Homo sapiens (human)
positive regulation of angiogenesisIntegrin beta-3Homo sapiens (human)
positive regulation of bone resorptionIntegrin beta-3Homo sapiens (human)
symbiont entry into host cellIntegrin beta-3Homo sapiens (human)
platelet-derived growth factor receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
positive regulation of fibroblast proliferationIntegrin beta-3Homo sapiens (human)
mesodermal cell differentiationIntegrin beta-3Homo sapiens (human)
positive regulation of smooth muscle cell proliferationIntegrin beta-3Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationIntegrin beta-3Homo sapiens (human)
negative regulation of lipoprotein metabolic processIntegrin beta-3Homo sapiens (human)
negative chemotaxisIntegrin beta-3Homo sapiens (human)
regulation of release of sequestered calcium ion into cytosolIntegrin beta-3Homo sapiens (human)
regulation of serotonin uptakeIntegrin beta-3Homo sapiens (human)
angiogenesis involved in wound healingIntegrin beta-3Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeIntegrin beta-3Homo sapiens (human)
platelet aggregationIntegrin beta-3Homo sapiens (human)
cellular response to mechanical stimulusIntegrin beta-3Homo sapiens (human)
cellular response to xenobiotic stimulusIntegrin beta-3Homo sapiens (human)
positive regulation of glomerular mesangial cell proliferationIntegrin beta-3Homo sapiens (human)
blood coagulation, fibrin clot formationIntegrin beta-3Homo sapiens (human)
maintenance of postsynaptic specialization structureIntegrin beta-3Homo sapiens (human)
regulation of postsynaptic neurotransmitter receptor internalizationIntegrin beta-3Homo sapiens (human)
regulation of postsynaptic neurotransmitter receptor diffusion trappingIntegrin beta-3Homo sapiens (human)
positive regulation of substrate adhesion-dependent cell spreadingIntegrin beta-3Homo sapiens (human)
positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
regulation of trophoblast cell migrationIntegrin beta-3Homo sapiens (human)
regulation of extracellular matrix organizationIntegrin beta-3Homo sapiens (human)
cellular response to insulin-like growth factor stimulusIntegrin beta-3Homo sapiens (human)
negative regulation of endothelial cell apoptotic processIntegrin beta-3Homo sapiens (human)
positive regulation of T cell migrationIntegrin beta-3Homo sapiens (human)
cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of leukocyte migrationIntegrin alpha-IIbHomo sapiens (human)
cell-matrix adhesionIntegrin alpha-IIbHomo sapiens (human)
integrin-mediated signaling pathwayIntegrin alpha-IIbHomo sapiens (human)
angiogenesisIntegrin alpha-IIbHomo sapiens (human)
cell-cell adhesionIntegrin alpha-IIbHomo sapiens (human)
cell adhesion mediated by integrinIntegrin alpha-IIbHomo sapiens (human)
biogenic amine metabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
positive regulation of signal transductionAmine oxidase [flavin-containing] AHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
response to xenobiotic stimulusAmine oxidase [flavin-containing] BHomo sapiens (human)
response to toxic substanceAmine oxidase [flavin-containing] BHomo sapiens (human)
response to aluminum ionAmine oxidase [flavin-containing] BHomo sapiens (human)
response to selenium ionAmine oxidase [flavin-containing] BHomo sapiens (human)
negative regulation of serotonin secretionAmine oxidase [flavin-containing] BHomo sapiens (human)
phenylethylamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
substantia nigra developmentAmine oxidase [flavin-containing] BHomo sapiens (human)
response to lipopolysaccharideAmine oxidase [flavin-containing] BHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to ethanolAmine oxidase [flavin-containing] BHomo sapiens (human)
positive regulation of dopamine metabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
hydrogen peroxide biosynthetic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to corticosteroneAmine oxidase [flavin-containing] BHomo sapiens (human)
proteolysisProteasome subunit beta type-5Homo sapiens (human)
response to oxidative stressProteasome subunit beta type-5Homo sapiens (human)
proteasome-mediated ubiquitin-dependent protein catabolic processProteasome subunit beta type-5Homo sapiens (human)
positive regulation of immunoglobulin productionInterleukin-2Homo sapiens (human)
positive regulation of plasma cell differentiationInterleukin-2Homo sapiens (human)
negative regulation of B cell apoptotic processInterleukin-2Homo sapiens (human)
positive regulation of B cell proliferationInterleukin-2Homo sapiens (human)
positive regulation of activated T cell proliferationInterleukin-2Homo sapiens (human)
negative regulation of protein phosphorylationInterleukin-2Homo sapiens (human)
adaptive immune responseInterleukin-2Homo sapiens (human)
leukocyte activation involved in immune responseInterleukin-2Homo sapiens (human)
transcription by RNA polymerase IIInterleukin-2Homo sapiens (human)
immune responseInterleukin-2Homo sapiens (human)
cell adhesionInterleukin-2Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationInterleukin-2Homo sapiens (human)
protein kinase C-activating G protein-coupled receptor signaling pathwayInterleukin-2Homo sapiens (human)
cell-cell signalingInterleukin-2Homo sapiens (human)
positive regulation of cell population proliferationInterleukin-2Homo sapiens (human)
natural killer cell activationInterleukin-2Homo sapiens (human)
T cell differentiationInterleukin-2Homo sapiens (human)
positive regulation of cell growthInterleukin-2Homo sapiens (human)
positive regulation of type II interferon productionInterleukin-2Homo sapiens (human)
positive regulation of interleukin-17 productionInterleukin-2Homo sapiens (human)
positive regulation of tissue remodelingInterleukin-2Homo sapiens (human)
interleukin-2-mediated signaling pathwayInterleukin-2Homo sapiens (human)
positive regulation of tyrosine phosphorylation of STAT proteinInterleukin-2Homo sapiens (human)
negative regulation of apoptotic processInterleukin-2Homo sapiens (human)
response to ethanolInterleukin-2Homo sapiens (human)
positive regulation of regulatory T cell differentiationInterleukin-2Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIInterleukin-2Homo sapiens (human)
regulation of T cell homeostatic proliferationInterleukin-2Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesInterleukin-2Homo sapiens (human)
negative regulation of lymphocyte proliferationInterleukin-2Homo sapiens (human)
negative regulation of inflammatory responseInterleukin-2Homo sapiens (human)
positive regulation of inflammatory responseInterleukin-2Homo sapiens (human)
activated T cell proliferationInterleukin-2Homo sapiens (human)
positive regulation of dendritic spine developmentInterleukin-2Homo sapiens (human)
extrinsic apoptotic signaling pathway in absence of ligandInterleukin-2Homo sapiens (human)
response to tacrolimusInterleukin-2Homo sapiens (human)
negative regulation of T-helper 17 cell differentiationInterleukin-2Homo sapiens (human)
regulation of CD4-positive, alpha-beta T cell proliferationInterleukin-2Homo sapiens (human)
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (90)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
monooxygenase activityCytochrome P450 1A1Homo sapiens (human)
iron ion bindingCytochrome P450 1A1Homo sapiens (human)
protein bindingCytochrome P450 1A1Homo sapiens (human)
arachidonic acid monooxygenase activityCytochrome P450 1A1Homo sapiens (human)
oxidoreductase activityCytochrome P450 1A1Homo sapiens (human)
oxidoreductase activity, acting on diphenols and related substances as donorsCytochrome P450 1A1Homo sapiens (human)
flavonoid 3'-monooxygenase activityCytochrome P450 1A1Homo sapiens (human)
oxygen bindingCytochrome P450 1A1Homo sapiens (human)
enzyme bindingCytochrome P450 1A1Homo sapiens (human)
heme bindingCytochrome P450 1A1Homo sapiens (human)
Hsp70 protein bindingCytochrome P450 1A1Homo sapiens (human)
demethylase activityCytochrome P450 1A1Homo sapiens (human)
Hsp90 protein bindingCytochrome P450 1A1Homo sapiens (human)
aromatase activityCytochrome P450 1A1Homo sapiens (human)
vitamin D 24-hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
long-chain fatty acid omega-hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1A1Homo sapiens (human)
long-chain fatty acid omega-1 hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
fibroblast growth factor bindingIntegrin beta-3Homo sapiens (human)
C-X3-C chemokine bindingIntegrin beta-3Homo sapiens (human)
insulin-like growth factor I bindingIntegrin beta-3Homo sapiens (human)
neuregulin bindingIntegrin beta-3Homo sapiens (human)
virus receptor activityIntegrin beta-3Homo sapiens (human)
fibronectin bindingIntegrin beta-3Homo sapiens (human)
protease bindingIntegrin beta-3Homo sapiens (human)
protein disulfide isomerase activityIntegrin beta-3Homo sapiens (human)
protein kinase C bindingIntegrin beta-3Homo sapiens (human)
platelet-derived growth factor receptor bindingIntegrin beta-3Homo sapiens (human)
integrin bindingIntegrin beta-3Homo sapiens (human)
protein bindingIntegrin beta-3Homo sapiens (human)
coreceptor activityIntegrin beta-3Homo sapiens (human)
enzyme bindingIntegrin beta-3Homo sapiens (human)
identical protein bindingIntegrin beta-3Homo sapiens (human)
vascular endothelial growth factor receptor 2 bindingIntegrin beta-3Homo sapiens (human)
metal ion bindingIntegrin beta-3Homo sapiens (human)
cell adhesion molecule bindingIntegrin beta-3Homo sapiens (human)
extracellular matrix bindingIntegrin beta-3Homo sapiens (human)
fibrinogen bindingIntegrin beta-3Homo sapiens (human)
protein bindingIntegrin alpha-IIbHomo sapiens (human)
identical protein bindingIntegrin alpha-IIbHomo sapiens (human)
metal ion bindingIntegrin alpha-IIbHomo sapiens (human)
extracellular matrix bindingIntegrin alpha-IIbHomo sapiens (human)
molecular adaptor activityIntegrin alpha-IIbHomo sapiens (human)
fibrinogen bindingIntegrin alpha-IIbHomo sapiens (human)
integrin bindingIntegrin alpha-IIbHomo sapiens (human)
protein bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
electron transfer activityAmine oxidase [flavin-containing] BHomo sapiens (human)
identical protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
threonine-type endopeptidase activityProteasome subunit beta type-5Homo sapiens (human)
protein bindingProteasome subunit beta type-5Homo sapiens (human)
peptidase activityProteasome subunit beta type-5Homo sapiens (human)
endopeptidase activityProteasome subunit beta type-5Homo sapiens (human)
cytokine activityInterleukin-2Homo sapiens (human)
interleukin-2 receptor bindingInterleukin-2Homo sapiens (human)
protein bindingInterleukin-2Homo sapiens (human)
growth factor activityInterleukin-2Homo sapiens (human)
kinase activator activityInterleukin-2Homo sapiens (human)
carbohydrate bindingInterleukin-2Homo sapiens (human)
kappa-type opioid receptor bindingInterleukin-2Homo sapiens (human)
glycosphingolipid bindingInterleukin-2Homo sapiens (human)
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (65)

Processvia Protein(s)Taxonomy
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
mitochondrial inner membraneCytochrome P450 1A1Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 1A1Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A1Homo sapiens (human)
glutamatergic synapseIntegrin beta-3Homo sapiens (human)
nucleusIntegrin beta-3Homo sapiens (human)
nucleoplasmIntegrin beta-3Homo sapiens (human)
plasma membraneIntegrin beta-3Homo sapiens (human)
cell-cell junctionIntegrin beta-3Homo sapiens (human)
focal adhesionIntegrin beta-3Homo sapiens (human)
external side of plasma membraneIntegrin beta-3Homo sapiens (human)
cell surfaceIntegrin beta-3Homo sapiens (human)
apical plasma membraneIntegrin beta-3Homo sapiens (human)
platelet alpha granule membraneIntegrin beta-3Homo sapiens (human)
lamellipodium membraneIntegrin beta-3Homo sapiens (human)
filopodium membraneIntegrin beta-3Homo sapiens (human)
microvillus membraneIntegrin beta-3Homo sapiens (human)
ruffle membraneIntegrin beta-3Homo sapiens (human)
integrin alphav-beta3 complexIntegrin beta-3Homo sapiens (human)
melanosomeIntegrin beta-3Homo sapiens (human)
synapseIntegrin beta-3Homo sapiens (human)
postsynaptic membraneIntegrin beta-3Homo sapiens (human)
extracellular exosomeIntegrin beta-3Homo sapiens (human)
integrin alphaIIb-beta3 complexIntegrin beta-3Homo sapiens (human)
glycinergic synapseIntegrin beta-3Homo sapiens (human)
integrin complexIntegrin beta-3Homo sapiens (human)
protein-containing complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-PKCalpha complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-IGF-1-IGF1R complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-HMGB1 complexIntegrin beta-3Homo sapiens (human)
receptor complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-vitronectin complexIntegrin beta-3Homo sapiens (human)
alpha9-beta1 integrin-ADAM8 complexIntegrin beta-3Homo sapiens (human)
focal adhesionIntegrin beta-3Homo sapiens (human)
cell surfaceIntegrin beta-3Homo sapiens (human)
synapseIntegrin beta-3Homo sapiens (human)
plasma membraneIntegrin alpha-IIbHomo sapiens (human)
focal adhesionIntegrin alpha-IIbHomo sapiens (human)
cell surfaceIntegrin alpha-IIbHomo sapiens (human)
platelet alpha granule membraneIntegrin alpha-IIbHomo sapiens (human)
extracellular exosomeIntegrin alpha-IIbHomo sapiens (human)
integrin alphaIIb-beta3 complexIntegrin alpha-IIbHomo sapiens (human)
blood microparticleIntegrin alpha-IIbHomo sapiens (human)
integrin complexIntegrin alpha-IIbHomo sapiens (human)
external side of plasma membraneIntegrin alpha-IIbHomo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] AHomo sapiens (human)
cytosolAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial envelopeAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] BHomo sapiens (human)
dendriteAmine oxidase [flavin-containing] BHomo sapiens (human)
neuronal cell bodyAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
nucleusProteasome subunit beta type-5Homo sapiens (human)
cytoplasmProteasome subunit beta type-5Homo sapiens (human)
proteasome complexProteasome subunit beta type-5Homo sapiens (human)
nucleusProteasome subunit beta type-5Homo sapiens (human)
nucleoplasmProteasome subunit beta type-5Homo sapiens (human)
centrosomeProteasome subunit beta type-5Homo sapiens (human)
cytosolProteasome subunit beta type-5Homo sapiens (human)
extracellular exosomeProteasome subunit beta type-5Homo sapiens (human)
proteasome core complexProteasome subunit beta type-5Homo sapiens (human)
proteasome core complex, beta-subunit complexProteasome subunit beta type-5Homo sapiens (human)
cytosolProteasome subunit beta type-5Homo sapiens (human)
extracellular spaceInterleukin-2Homo sapiens (human)
extracellular regionInterleukin-2Homo sapiens (human)
extracellular spaceInterleukin-2Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (281)

Assay IDTitleYearJournalArticle
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID469806Estrogenic activity in luciferase transfected human T47D cells assessed as drug level causing stimulation of cell proliferation equivalent to 100 pM estradiol by luciferase reporter gene assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID1453623Inhibition of recombinant human PTP1B using p-nitrophenyl phosphate as substrate at 10 uM after 30 mins relative to control2017Bioorganic & medicinal chemistry, 07-15, Volume: 25, Issue:14
Screening for bioactive natural products from a 67-compound library of Glycyrrhiza inflata.
AID334920Inhibition of TPA-stimulated [32P] incorporation into phospholipids in human HeLa cells at 50 uM after 1 hr
AID338053Antibacterial activity against Bacillus subtilis ATCC 6633 after 16 hrs by microdilution assay
AID334923Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed as early antigen induction at 100 molar ratio after 48 hrs by indirect immunofluorescence technique relative to TPA
AID1166541Effect on adipogenesis in mouse 3T3L1 cells assessed as reduction in Cebpa gene expression at 5 to 50 uM after 8 days by real time quantitative PCR analysis relative to vehicle-treated control2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPARγ partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes.
AID1073041Antiviral activity against Influenza A virus J/8178/09 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 48 hrs2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Computer-guided approach to access the anti-influenza activity of licorice constituents.
AID1764423Binding affinity to pig pancreatic lipase type 2 assessed as Stern-Volmer quenching constant at 27 degC measured after 1 min by Stern-Volmer plot analysis2021Journal of natural products, 03-26, Volume: 84, Issue:3
Natural Isoflavones and Semisynthetic Derivatives as Pancreatic Lipase Inhibitors.
AID1386834Antagonist activity at PR-b (unknown origin) expressed in Ishikawa cells assessed as inhibition of progesterone-induced PRE activity at 50 uM after 24 hrs by luciferase reporter gene based luminescence assay2018Journal of natural products, 09-28, Volume: 81, Issue:9
Irilone from Red Clover ( Trifolium pratense) Potentiates Progesterone Signaling.
AID1484046Antiproliferative activity against human A549 cells at 10 uM after 24 hrs by MTS assay relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Glycybridins A-K, Bioactive Phenolic Compounds from Glycyrrhiza glabra.
AID366285Inhibition of Influenza A PR/8/34 H1N1 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay2008Bioorganic & medicinal chemistry, Aug-01, Volume: 16, Issue:15
Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities.
AID398789Antifungal activity against Candida albicans ATCC 10231 at 100 mcg/ml by agar-dilution streak method
AID334930Cytotoxicity in human HeLa cells assessed as decrease in cell number at 50 uM after 1 hr
AID1764439Non-competitive inhibition of pig pancreatic lipase type 2 using varying concentrations of p-nitrophenyl butyrate as substrate measured every 1 min for 30 mins by Lineweaver-Burk plot analysis2021Journal of natural products, 03-26, Volume: 84, Issue:3
Natural Isoflavones and Semisynthetic Derivatives as Pancreatic Lipase Inhibitors.
AID266700Antiproliferative activity against human MDA-MB-468 cell line2006Journal of medicinal chemistry, Jun-29, Volume: 49, Issue:13
Structural studies on bioactive compounds. 40.(1) Synthesis and biological properties of fluoro-, methoxyl-, and amino-substituted 3-phenyl-4H-1-benzopyran-4-ones and a comparison of their antitumor activities with the activities of related 2-phenylbenzot
AID1464283Cytotoxicity against mouse BV2 cells assessed as reduction in cell viability at 1 to 100 uM after 24 hrs in presence of LPS by MTT assay2017Bioorganic & medicinal chemistry letters, 10-15, Volume: 27, Issue:20
Natural neuro-inflammatory inhibitors from Caragana turfanensis.
AID366284Inhibition of Influenza A Jinan/15/90 H3N2 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay2008Bioorganic & medicinal chemistry, Aug-01, Volume: 16, Issue:15
Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities.
AID334931Displacement of [3H]TPA from TPA receptor in ICR mouse epidermal particulate fraction by Me2CO filter method
AID1764422Inhibition of pig pancreatic lipase type 2 using p-nitrophenyl butyrate as substrate preincubated with enzyme for 10 mins followed by susbtrate addition and measured after 30 mins by spectrophotometric analysis2021Journal of natural products, 03-26, Volume: 84, Issue:3
Natural Isoflavones and Semisynthetic Derivatives as Pancreatic Lipase Inhibitors.
AID1171166Inhibition of RANKL-induced c-FOS mRNA expression in ICR mouse BMMC at 5 uM incubated for 12 hrs by qRT-PCR method2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway.
AID439367Agonist activity at human PPARgamma expressed in HEK293 cells co-transfected with PPRE assessed as beta-galactosidase signal at 5 uM after 48 hrs by reporter gene assay relative to control2009Journal of medicinal chemistry, Nov-12, Volume: 52, Issue:21
7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists.
AID1171161Inhibition of RANKL/M-CSF-stimulated MIP-1alpha protein expression in ICR mouse BMMC at 1 to 10 uM incubated for 48 hrs by ELISA method relative to untreated control2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway.
AID266703Antiproliferative activity against human HCT116 cell line2006Journal of medicinal chemistry, Jun-29, Volume: 49, Issue:13
Structural studies on bioactive compounds. 40.(1) Synthesis and biological properties of fluoro-, methoxyl-, and amino-substituted 3-phenyl-4H-1-benzopyran-4-ones and a comparison of their antitumor activities with the activities of related 2-phenylbenzot
AID332396Toxicity in brine shrimp larvae1994Journal of natural products, Mar, Volume: 57, Issue:3
Kneglomeratanol, kneglomeratanones A and B, and related bioactive compounds from Knema glomerata.
AID1166535Effect on adipogenesis in mouse 3T3L1 cells assessed as increase in lipid accumulation at 5 to 50 uM measured on day 8 by oil red o assay2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPARγ partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes.
AID1166544Effect on adipogenesis in mouse 3T3L1 cells assessed as reduction in Adipoq gene expression at 5 to 50 uM after 8 days by real time quantitative PCR analysis relative to vehicle-treated control2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPARγ partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes.
AID1434704Antineuroinflammatory activity in mouse N9 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess assay2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Natural potential neuroinflammatory inhibitors from Alhagi sparsifolia Shap.
AID1166542Effect on adipogenesis in mouse 3T3L1 cells assessed as increase in Srebf1 gene expression at 5 to 50 uM after 8 days by real time quantitative PCR analysis relative to vehicle-treated control2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPARγ partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes.
AID1166567Competitive binding to human GST-tagged PPAR-gamma at <=100 uM by TR-FRET assay2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPARγ partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes.
AID338058Antifungal activity against Trichophyton mentagrophytes ATCC 9533 after 3 days by microdilution assay
AID1764425Binding affinity to pig pancreatic lipase type 2 assessed as Stern-Volmer quenching constant at 37 degC measured after 1 min by Stern-Volmer plot analysis2021Journal of natural products, 03-26, Volume: 84, Issue:3
Natural Isoflavones and Semisynthetic Derivatives as Pancreatic Lipase Inhibitors.
AID1453619Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production at 10 uM after 24 hrs by Griess reagent based assay relative to control2017Bioorganic & medicinal chemistry, 07-15, Volume: 25, Issue:14
Screening for bioactive natural products from a 67-compound library of Glycyrrhiza inflata.
AID377880Toxicity in C57B mouse assessed as induction of adverse grooming behavior at 40 mg/kg, po administered once daily for 3 days2000Journal of natural products, Oct, Volume: 63, Issue:10
Antigiardial activity of isoflavones from Dalbergia frutescens bark.
AID1166534Effect on adipogenesis in mouse 3T3L1 cells assessed as increase in lipid accumulation at 5 to 50 uM measured on day 8 by fluorescence-based AdipoRed assay2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPARγ partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes.
AID1166560Effect on lipolysis in mouse 3T3L1 cells assessed as reduction in glycerol level at 5 to 50 uM after 48 hrs by UV-Vis spectrophotometry2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPARγ partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1073040Antiviral activity against Influenza A virus (A/Hong Kong/1/1968(H3N2)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect after 48 hrs2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Computer-guided approach to access the anti-influenza activity of licorice constituents.
AID338055Antifungal activity against Candida albicans ATCC 10259 after 3 days by microdilution assay
AID1166558Cytotoxicity against mouse 3T3L1 cells assessed as LDH release at 50 uM after 48 hrs2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPARγ partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes.
AID367727Induction of mineralization in Sprague-Dawley rat calvaria derived primary osteoblast after 7 days by Alizarin Red S staining2009Bioorganic & medicinal chemistry letters, Feb-01, Volume: 19, Issue:3
Osteogenic activity of constituents from Butea monosperma.
AID266705Inhibition of CYP1A1 by EROD assay2006Journal of medicinal chemistry, Jun-29, Volume: 49, Issue:13
Structural studies on bioactive compounds. 40.(1) Synthesis and biological properties of fluoro-, methoxyl-, and amino-substituted 3-phenyl-4H-1-benzopyran-4-ones and a comparison of their antitumor activities with the activities of related 2-phenylbenzot
AID1171171Inhibition of RANKL-induced NFATc1 mRNA expression in ICR mouse BMMC at 5 uM incubated for 12 hrs by qRT-PCR method2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway.
AID377886Antifungal activity against Giardia intestinalis infected in C57B mouse assessed as increase in disease cure rate at 10 mg/day administered 3 day postinfection for 4 days2000Journal of natural products, Oct, Volume: 63, Issue:10
Antigiardial activity of isoflavones from Dalbergia frutescens bark.
AID378966Antitrypanosomal activity against Trypanosoma brucei brucei MITat 1.2 variant 221 after 72 hrs2006Journal of natural products, Jan, Volume: 69, Issue:1
Isoflavonoids and other compounds from Psorothamnus arborescens with antiprotozoal activities.
AID334926Cytotoxicity against human Raji cells assessed as cell viability at 1000 molar ratio
AID1166577Effect on adipogenesis in mature mouse 3T3L1 cells assessed as upregulation of Sirt1 gene expression2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPARγ partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes.
AID1632839Inhibition of recombinant human MAO-B expressed in baculovirus infected BTI insect cells preincubated for 10 mins followed by addition of benzylamine as substrate2016Bioorganic & medicinal chemistry letters, 10-01, Volume: 26, Issue:19
Potent selective monoamine oxidase B inhibition by maackiain, a pterocarpan from the roots of Sophora flavescens.
AID480102Increase in PPARgamma mRNA levels in mouse 3T3L1 cells at 100 umol/L by RT-PCR2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Synthesis and biological evaluation of isoflavone fatty acid esters with potential weight loss and hypolipidemic activities.
AID469802Estrogenic activity in human MCF7 cells assessed as drug level causing stimulation of cell proliferation equivalent to 10 pM estradiol after 96 hrs by alamar blue assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID1453621Inhibition of LPS-induced NF-kappaB transcription (unknown origin) expressed in human SW480 cells at 10 uM by luciferase reporter gene assay2017Bioorganic & medicinal chemistry, 07-15, Volume: 25, Issue:14
Screening for bioactive natural products from a 67-compound library of Glycyrrhiza inflata.
AID1171172Inhibition of RANKL-induced c-FOS protein expression in ICR mouse BMMC at 1 to 10 uM incubated for 12 hrs by Western blotting method2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway.
AID1166545Effect on adipogenesis in mouse 3T3L1 cells assessed as reduction in Pparg gene expression at 5 to 50 uM after 4 days by real time quantitative PCR analysis relative to vehicle-treated control2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPARγ partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes.
AID1764424Binding affinity to pig pancreatic lipase type 2 assessed as Stern-Volmer quenching constant at 32 degC measured after 1 min by Stern-Volmer plot analysis2021Journal of natural products, 03-26, Volume: 84, Issue:3
Natural Isoflavones and Semisynthetic Derivatives as Pancreatic Lipase Inhibitors.
AID398781Antibacterial activity against Escherichia coli ATCC 9637 at 100 mcg/ml by agar-dilution streak method
AID377888Antifungal activity against Giardia intestinalis infected in C57B mouse assessed as intestinal motile trophozoites count at 10 mg/day administered 3 day postinfection for 4 days2000Journal of natural products, Oct, Volume: 63, Issue:10
Antigiardial activity of isoflavones from Dalbergia frutescens bark.
AID404179Cytotoxicity against mouse colon 26-L5 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID1073033Inhibition of Clostridium perfringens neuraminidase by chemiluminescence based assay2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Computer-guided approach to access the anti-influenza activity of licorice constituents.
AID736345Agonist activity at human PPARdelta expressed in HEK293 cells cotransfected with PPREx4-TK-luc assessed as beta-galactosidase activity at 25 uM measured after 48 hrs relative to vehicle control2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
The discovery of novel isoflavone pan peroxisome proliferator-activated receptor agonists.
AID1764438Competitive inhibition of pig pancreatic lipase type 2 using varying concentrations of p-nitrophenyl butyrate as substrate measured every 1 min for 30 mins by Lineweaver-Burk plot analysis2021Journal of natural products, 03-26, Volume: 84, Issue:3
Natural Isoflavones and Semisynthetic Derivatives as Pancreatic Lipase Inhibitors.
AID1243355Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Isolation and structure elucidation of bioactive compounds from the roots of the Tunisian Ononis angustissima L.
AID266702Antiproliferative activity against human HT29 cell line2006Journal of medicinal chemistry, Jun-29, Volume: 49, Issue:13
Structural studies on bioactive compounds. 40.(1) Synthesis and biological properties of fluoro-, methoxyl-, and amino-substituted 3-phenyl-4H-1-benzopyran-4-ones and a comparison of their antitumor activities with the activities of related 2-phenylbenzot
AID1171164Inhibition of RANKL-stimulated NFkappaB (unknown origin) expressed in ICR mouse BMMC assessed as reduction in transcriptional activity at 1 to 10 uM incubated for 12 hrs by SEAP based reporter gene assay relative to untreated control2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway.
AID377877Antifungal activity against Giardia intestinalis ATCC 30888 assessed as impairment of parasite motility after 2 hrs2000Journal of natural products, Oct, Volume: 63, Issue:10
Antigiardial activity of isoflavones from Dalbergia frutescens bark.
AID1873265Anti-obesity activity in male C57BL/6 mouse model of high-fat diet induced obesity assessed as body weight change at 50 mg/kg, po administered once a day for 8 weeks relative to control2022European journal of medicinal chemistry, Jul-05, Volume: 237Recent advances in natural anti-obesity compounds and derivatives based on in vivo evidence: A mini-review.
AID469803Estrogenic activity in luciferase transfected human MCF7 cells assessed as drug level causing stimulation of cell proliferation equivalent to 10 pM estradiol by luciferase reporter gene assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID1764428Binding affinity to pig pancreatic lipase type 2 assessed as decrease in fluorescence intensity at 37 degC measured after 1 min by fluorescence spectral analysis2021Journal of natural products, 03-26, Volume: 84, Issue:3
Natural Isoflavones and Semisynthetic Derivatives as Pancreatic Lipase Inhibitors.
AID1166539Cytotoxicity against mouse 3T3L1 cells assessed as effect on lactate dehydrogenase release at 5 to 50 uM measured on day 82014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPARγ partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes.
AID332400Cytotoxicity against human HT-29 cells after 7 days1994Journal of natural products, Mar, Volume: 57, Issue:3
Kneglomeratanol, kneglomeratanones A and B, and related bioactive compounds from Knema glomerata.
AID1204997Antioxidant activity of the compound assessed as inhibition of ABTS radicals after 20 mins by spectrophotometric analysis2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Dual high-resolution α-glucosidase and radical scavenging profiling combined with HPLC-HRMS-SPE-NMR for identification of minor and major constituents directly from the crude extract of Pueraria lobata.
AID666608Cytotoxicity against human SH-SY5Y cells after 72 hrs by MTT assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and antitumor activity of formononetin nitrogen mustard derivatives.
AID334921Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed as early antigen induction at 10000 molar ratio after 48 hrs by indirect immunofluorescence technique relative to TPA
AID1073045Inhibition of Influenza A virus J/8178/09 neuraminidase by chemiluminescence based assay2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Computer-guided approach to access the anti-influenza activity of licorice constituents.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID398788Antibacterial activity against Mycobacterium smegmatis ATCC 607 at 100 mcg/ml by agar-dilution streak method
AID338974Inhibition of cow milk xanthine oxidase at 50 ug/mL
AID1764433Binding affinity to pig pancreatic lipase type 2 assessed as quenching rate constant at 32 degC measured after 1 min by Stern-Volmer plot analysis2021Journal of natural products, 03-26, Volume: 84, Issue:3
Natural Isoflavones and Semisynthetic Derivatives as Pancreatic Lipase Inhibitors.
AID1171159Inhibition of RANKL/M-CSF-stimulated MCP1 protein expression in ICR mouse BMMC at 1 to 10 uM incubated for 48 hrs by ELISA method relative to untreated control2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway.
AID469805Estrogenic activity in luciferase transfected human T47D cells assessed as drug level causing stimulation of cell proliferation equivalent to 10 pM estradiol by luciferase reporter gene assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID378965Antileishmanial activity against Leishmania donovani MHOM/SD/62/IS-CL2D axenic amastigotes after 3 days2006Journal of natural products, Jan, Volume: 69, Issue:1
Isoflavonoids and other compounds from Psorothamnus arborescens with antiprotozoal activities.
AID1073034Inhibition of Clostridium perfringens neuraminidase by fluorescence based assay2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Computer-guided approach to access the anti-influenza activity of licorice constituents.
AID1166551Effect on adipogenesis in mouse 3T3L1 cells in DI media assessed as increase in fat-laden mature adipocytes after 8 days by oil red o assay2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPARγ partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes.
AID334932Cytotoxicity in human HeLa cells assessed as effect on cell viability at 50 uM after 1 hr
AID1227827Cytotoxicity against mouse BV2 cells assessed as reduction of cell viability at IC50 after 24 hrs by MTT assay2015Bioorganic & medicinal chemistry letters, Jan-01, Volume: 25, Issue:1
Natural therapeutic agents for neurodegenerative diseases from a traditional herbal medicine Pongamia pinnata (L.) Pierre.
AID305716Antiproliferative activity against human U937 cells after 48 hrs by WST-8 assay2007Bioorganic & medicinal chemistry, Feb-01, Volume: 15, Issue:3
Rotenoids and flavonoids with anti-invasion of HT1080, anti-proliferation of U937, and differentiation-inducing activity in HL-60 from Erycibe expansa.
AID404182Cytotoxicity against human A549 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID1156796Binding affinity to Bcl-xL (unknown origin)2014European journal of medicinal chemistry, Aug-18, Volume: 83Prediction of anti-tumor chemical probes of a traditional Chinese medicine formula by HPLC fingerprinting combined with molecular docking.
AID1166538Cytotoxicity against mouse 3T3L1 cells assessed as effect on lactate dehydrogenase release at 5 to 50 uM measured on day 22014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPARγ partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes.
AID380063Cytotoxicity against human HL60 cells after 96 hrs by MTT assay2000Journal of natural products, May, Volume: 63, Issue:5
Cytotoxic lavandulyl flavanones from Sophora flavescens.
AID1764429Binding affinity to pig pancreatic lipase type 2 assessed as bathochromic shift of maximum fluorescence intensity at 27 degC measured after 1 min by fluorescence spectral analysis2021Journal of natural products, 03-26, Volume: 84, Issue:3
Natural Isoflavones and Semisynthetic Derivatives as Pancreatic Lipase Inhibitors.
AID377878Antifungal activity against Giardia intestinalis ATCC 30888 assessed as impairment of parasite motility after 4 hrs2000Journal of natural products, Oct, Volume: 63, Issue:10
Antigiardial activity of isoflavones from Dalbergia frutescens bark.
AID1073044Inhibition of Influenza A virus (A/Puerto Rico/8/1934(H1N1)) neuraminidase by chemiluminescence based assay2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Computer-guided approach to access the anti-influenza activity of licorice constituents.
AID1484039Activation of Nrf2 (unknown origin) expressed in human HepG2 cells at 10 uM after 6 hrs by ARE-driven luciferase reporter gene assay relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Glycybridins A-K, Bioactive Phenolic Compounds from Glycyrrhiza glabra.
AID377890Antimicrobial activity against Trichomonas up to 25 ug/mL2000Journal of natural products, Oct, Volume: 63, Issue:10
Antigiardial activity of isoflavones from Dalbergia frutescens bark.
AID1764437Binding affinity to pig pancreatic lipase type 2 assessed as binding constant at 37 degC measured after 1 min by Stern-Volmer plot analysis2021Journal of natural products, 03-26, Volume: 84, Issue:3
Natural Isoflavones and Semisynthetic Derivatives as Pancreatic Lipase Inhibitors.
AID378967Cytotoxicity against african green monkey Vero cells2006Journal of natural products, Jan, Volume: 69, Issue:1
Isoflavonoids and other compounds from Psorothamnus arborescens with antiprotozoal activities.
AID1204650Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of microbial growth at 10 uM after 5 to 8 days by MABA method2015Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
Synthesis, antimycobacterial evaluation and pharmacophore modeling of analogues of the natural product formononetin.
AID1484047Antiproliferative activity against human MCF7 cells at 10 uM after 24 hrs by MTS assay relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Glycybridins A-K, Bioactive Phenolic Compounds from Glycyrrhiza glabra.
AID305715Antiproliferative activity against human U937 cells after 24 hrs by WST-8 assay2007Bioorganic & medicinal chemistry, Feb-01, Volume: 15, Issue:3
Rotenoids and flavonoids with anti-invasion of HT1080, anti-proliferation of U937, and differentiation-inducing activity in HL-60 from Erycibe expansa.
AID1453614Growth inhibition of human MCF7 cells at 10 uM after 24 hrs by MTS assay relative to control2017Bioorganic & medicinal chemistry, 07-15, Volume: 25, Issue:14
Screening for bioactive natural products from a 67-compound library of Glycyrrhiza inflata.
AID1171168Inhibition of RANKL-stimulated ERK phosphorylation in ICR mouse BMMC at 1 to 10 uM incubated for 12 hrs by Western blotting method2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway.
AID1386839Agonist activity at PR-b (unknown origin) expressed in Ishikawa cells assessed as increase in progesterone-induced PRE activity at 1 uM after 24 hrs by luciferase reporter gene based luminescence assay2018Journal of natural products, 09-28, Volume: 81, Issue:9
Irilone from Red Clover ( Trifolium pratense) Potentiates Progesterone Signaling.
AID666611Cytotoxicity against human HeLa cells after 72 hrs by MTT assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and antitumor activity of formononetin nitrogen mustard derivatives.
AID358614Cytotoxicity against human KB cells2001Journal of natural products, Nov, Volume: 64, Issue:11
Macharistol, a new cytotoxic cinnamylphenol from the stems of Machaerium aristulatum.
AID1166549Effect on adipogenesis in mouse 3T3L1 cells assessed as reduction in Adipoq gene expression at 5 to 50 uM after 4 days by real time quantitative PCR analysis relative to vehicle-treated control2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPARγ partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes.
AID1171170Inhibition of RANKL-stimulated p38 phosphorylation in ICR mouse BMMC at 1 to 10 uM incubated for 12 hrs by Western blotting method2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway.
AID1764434Binding affinity to pig pancreatic lipase type 2 assessed as quenching rate constant at 37 degC measured after 1 min by Stern-Volmer plot analysis2021Journal of natural products, 03-26, Volume: 84, Issue:3
Natural Isoflavones and Semisynthetic Derivatives as Pancreatic Lipase Inhibitors.
AID266701Antiproliferative activity against human MCF7 cell line2006Journal of medicinal chemistry, Jun-29, Volume: 49, Issue:13
Structural studies on bioactive compounds. 40.(1) Synthesis and biological properties of fluoro-, methoxyl-, and amino-substituted 3-phenyl-4H-1-benzopyran-4-ones and a comparison of their antitumor activities with the activities of related 2-phenylbenzot
AID1171158Inhibition of RANKL/M-CSF-stimulated IL-6 protein expression in ICR mouse BMMC at 1 to 10 uM incubated for 48 hrs by ELISA method relative to untreated control2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway.
AID404069In vivo antitumor activity against mouse L1210 cells
AID1073043Inhibition of oseltamivir-resistant Influenza A virus H1N1 B/55/08 neuraminidase by chemiluminescence based assay2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Computer-guided approach to access the anti-influenza activity of licorice constituents.
AID334928Cytotoxicity against human Raji cells assessed as cell viability at 10 molar ratio
AID1171160Inhibition of RANKL/M-CSF-stimulated RANTES protein expression in ICR mouse BMMC at 1 to 10 uM incubated for 48 hrs by ELISA method relative to untreated control2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway.
AID1156799Anticancer activity against human HepG2 cells assessed as cell viability after 24 hrs by MTT assay2014European journal of medicinal chemistry, Aug-18, Volume: 83Prediction of anti-tumor chemical probes of a traditional Chinese medicine formula by HPLC fingerprinting combined with molecular docking.
AID334637Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-aminoanthracene-induced mutation at 600 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID1632838Inhibition of recombinant human MAO-A expressed in baculovirus infected BTI insect cells preincubated for 10 mins followed by addition of kynuramine as substrate2016Bioorganic & medicinal chemistry letters, 10-01, Volume: 26, Issue:19
Potent selective monoamine oxidase B inhibition by maackiain, a pterocarpan from the roots of Sophora flavescens.
AID334925Cytotoxicity against human Raji cells assessed as cell viability at 10000 molar ratio
AID404181Cytotoxicity against mouse LLC cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID1171156Inhibition of RANKL/M-CSF-stimulated TNFalpha protein expression in ICR mouse BMMC at 1 to 10 uM incubated for 48 hrs by ELISA method relative to untreated control2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway.
AID338057Antifungal activity against Aspergillus niger ATCC 6275 after 3 days by microdilution assay
AID1171173Inhibition of RANKL-induced NFATc1 protein expression in ICR mouse BMMC at 1 to 10 uM incubated for 12 hrs by Western blotting method2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway.
AID1171157Inhibition of RANKL/M-CSF-stimulated IL-1beta protein expression in ICR mouse BMMC at 1 to 10 uM incubated for 48 hrs by ELISA method relative to untreated control2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway.
AID1166565Induction of lipolysis in mouse 3T3L1 cells assessed as up-regulation of Atgl gene exression by real time-qPCR analysis2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPARγ partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes.
AID1386844Induction of PR-b degradation in human Ishikawa cells up to 50 uM after 24 hrs by Western blot analysis2018Journal of natural products, 09-28, Volume: 81, Issue:9
Irilone from Red Clover ( Trifolium pratense) Potentiates Progesterone Signaling.
AID377875Antifungal activity against Giardia intestinalis ATCC 30888 after 48 hrs by XTT assay2000Journal of natural products, Oct, Volume: 63, Issue:10
Antigiardial activity of isoflavones from Dalbergia frutescens bark.
AID1633148Inhibition of chymotrypsin-like activity of purified human erythrocyte 20S proteasome assessed as decrease in AMC hydrolysis using Suc-LLVY-AMC as substrate preincubated for 10 mins and measured by fluorescence based method2019European journal of medicinal chemistry, Apr-01, Volume: 167Another look at phenolic compounds in cancer therapy the effect of polyphenols on ubiquitin-proteasome system.
AID404180Cytotoxicity against mouse B16-BL6 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1171150Inhibition of RANKL/M-CSF-stimulated osteoclastogenesis in ICR mouse BMMC assessed as reduction in TRAP positive multinucleated cells at 1 to 10 uM incubated for 7 days by light microscopy2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway.
AID332397Antitumor activity against Agrobacterium tumefaciens-induced crown gall tumors in potato by disk test relative to control1994Journal of natural products, Mar, Volume: 57, Issue:3
Kneglomeratanol, kneglomeratanones A and B, and related bioactive compounds from Knema glomerata.
AID1073036Induction of fluorescence at 100 uM relative to 4-methylumbelliferone2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Computer-guided approach to access the anti-influenza activity of licorice constituents.
AID1386838Antagonist activity at PR-b (unknown origin) expressed in Ishikawa cells assessed as inhibition of basal PRE activity at 50 uM after 24 hrs in absence of progesterone by luciferase reporter gene based luminescence assay2018Journal of natural products, 09-28, Volume: 81, Issue:9
Irilone from Red Clover ( Trifolium pratense) Potentiates Progesterone Signaling.
AID313354Cytotoxicity against human PANC1 cells in nutrient deprived medium after 24 hrs2008Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
Constituents of Brazilian red propolis and their preferential cytotoxic activity against human pancreatic PANC-1 cancer cell line in nutrient-deprived condition.
AID1166569Agonist activity at PPAR-gamma in mouse embryo fibroblast at 5 to 50 uM by transactivation assay relative to rosiglitazone2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPARγ partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes.
AID295283Inhibition of human SGLT1 expressed in COS1 cells assessed as [14C]methyl-alpha-D-glucopyranoside uptake at 50 uM2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Na+-glucose cotransporter (SGLT) inhibitory flavonoids from the roots of Sophora flavescens.
AID1073035Induction of fluorescence quenching at 100 uM relative to 4-methylumbelliferone2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Computer-guided approach to access the anti-influenza activity of licorice constituents.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1166540Effect on adipogenesis in mouse 3T3L1 cells assessed as reduction in Pparg gene expression at 5 to 50 uM after 8 days by real time quantitative PCR analysis relative to vehicle-treated control2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPARγ partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes.
AID1464282Antineuroinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced NO production after 24 hrs in presence of LPS by Griess reaction based assay2017Bioorganic & medicinal chemistry letters, 10-15, Volume: 27, Issue:20
Natural neuro-inflammatory inhibitors from Caragana turfanensis.
AID1171153Inhibition of RANKL protein expression in ICR mouse BMMC co-cultured with primary osteoblasts at 1 to 10 uM incubated for 48 hrs by ELISA method2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway.
AID1243356Antioxidant activity assessed as ABTS radical scavenging activity after 6 mins2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Isolation and structure elucidation of bioactive compounds from the roots of the Tunisian Ononis angustissima L.
AID1374882Antiinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced nitric oxide production2018Bioorganic & medicinal chemistry letters, 04-01, Volume: 28, Issue:6
Anti-inflammatory isoflavones and isoflavanones from the roots of Pongamia pinnata (L.) Pierre.
AID1764432Binding affinity to pig pancreatic lipase type 2 assessed as quenching rate constant at 27 degC measured after 1 min by Stern-Volmer plot analysis2021Journal of natural products, 03-26, Volume: 84, Issue:3
Natural Isoflavones and Semisynthetic Derivatives as Pancreatic Lipase Inhibitors.
AID1166550Effect on adipogenesis in mouse 3T3L1 cells in DI media assessed as increase in lipid accumulation after 8 days by fluorescence-based AdipoRed assay2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPARγ partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes.
AID1073042Inhibition of Influenza A virus (A/Hong Kong/1/1968(H3N2)) neuraminidase by chemiluminescence based assay2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Computer-guided approach to access the anti-influenza activity of licorice constituents.
AID377882Toxicity in C57B mouse assessed as adverse effect on body weight at 40 mg/kg, po administered once daily for 3 days2000Journal of natural products, Oct, Volume: 63, Issue:10
Antigiardial activity of isoflavones from Dalbergia frutescens bark.
AID377883Toxicity in C57B mouse assessed as induction of adverse effect on gross behavior at 40 mg/kg, po administered once daily for 3 days2000Journal of natural products, Oct, Volume: 63, Issue:10
Antigiardial activity of isoflavones from Dalbergia frutescens bark.
AID439368Agonist activity at human PPARgamma expressed in HEK293 cells co-transfected with PPRE assessed as beta-galactosidase signal at 25 uM after 48 hrs by reporter gene assay relative to control2009Journal of medicinal chemistry, Nov-12, Volume: 52, Issue:21
7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists.
AID1166575Activation of AMPK in mouse 3T3L1 cells assessed as AMPK phosphorylation at 50 uM after 5 to 48 hrs by Western blotting analysis2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPARγ partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes.
AID1453625Inhibition of mushroom tyrosinase at 10 uM using L-tyrosine as substrate incubated for 15 mins followed by substrate addition relative to control2017Bioorganic & medicinal chemistry, 07-15, Volume: 25, Issue:14
Screening for bioactive natural products from a 67-compound library of Glycyrrhiza inflata.
AID736341Agonist activity at human PPARdelta expressed in HEK293 cells cotransfected with PPREx4-TK-luc assessed as beta-galactosidase activity at 50 uM measured after 48 hrs relative to vehicle control2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
The discovery of novel isoflavone pan peroxisome proliferator-activated receptor agonists.
AID332398Cytotoxicity against human A549 cells after 7 days1994Journal of natural products, Mar, Volume: 57, Issue:3
Kneglomeratanol, kneglomeratanones A and B, and related bioactive compounds from Knema glomerata.
AID1484045Antiproliferative activity against human HepG2 cells at 10 uM after 24 hrs by MTS assay relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Glycybridins A-K, Bioactive Phenolic Compounds from Glycyrrhiza glabra.
AID666612Cytotoxicity against human SGC7901 cells after 72 hrs by MTT assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and antitumor activity of formononetin nitrogen mustard derivatives.
AID1764426Binding affinity to pig pancreatic lipase type 2 assessed as decrease in fluorescence intensity at 27 degC measured after 1 min by fluorescence spectral analysis2021Journal of natural products, 03-26, Volume: 84, Issue:3
Natural Isoflavones and Semisynthetic Derivatives as Pancreatic Lipase Inhibitors.
AID456317Antioxidant activity assessed as trolox equivalent by TEAC assay2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID1073032Selectivity ratio of IC50 for Clostridium perfringens neuraminidase to IC50 for Influenza A virus neuraminidase2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Computer-guided approach to access the anti-influenza activity of licorice constituents.
AID377887Antifungal activity against Giardia intestinalis infected in C57B mouse assessed as decrease in intestinal parasite load at 10 mg/day administered 3 day postinfection for 4 days2000Journal of natural products, Oct, Volume: 63, Issue:10
Antigiardial activity of isoflavones from Dalbergia frutescens bark.
AID404184Cytotoxicity against human HT1080 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID1437591Cytotoxicity against human PC3 cells assessed as inhibition of cell viability after 48 hrs by MTT assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Design and synthesis of formononetin-dithiocarbamate hybrids that inhibit growth and migration of PC-3 cells via MAPK/Wnt signaling pathways.
AID1171155Increase in OPG protein expression in RANKL-stimulated mouse primary osteoblasts co-cultured with ICR mouse BMMC at 1 to 10 uM incubated for 48 hrs by ELISA method relative to untreated control2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway.
AID338054Antibacterial activity against Escherichia coli ATCC 25922 after 16 hrs by microdilution assay
AID1171151Inhibition of RANKL/M-CSF-stimulated osteoclastogenesis in ICR mouse BMMC assessed as reduction in TRAP positive multinucleated cells at 1 to 10 uM incubated for 7 days by light microscopy relative to untreated control2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway.
AID756490Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Inhibitory constituents of the heartwood of Dalbergia odorifera on nitric oxide production in RAW 264.7 macrophages.
AID1452998Inhibition of CYP1B1 in human liver microsomes coexpressing recombinant human cytochrome P450 oxidoreductase using 7-ethoxyresorufin as substrate after 3 mins in presence of NADP+ by fluorescence assay2017European journal of medicinal chemistry, Jul-28, Volume: 135Inhibitors of cytochrome P450 (CYP) 1B1.
AID1453616Growth inhibition of human HepG2 cells at 10 uM after 24 hrs by MTS assay relative to control2017Bioorganic & medicinal chemistry, 07-15, Volume: 25, Issue:14
Screening for bioactive natural products from a 67-compound library of Glycyrrhiza inflata.
AID334929Inhibition of EBV-early antigen activation in human Raji cells assessed as early antigen activation at 320 nM
AID756489Cytotoxicity against mouse RAW264.7 cells by CCK assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Inhibitory constituents of the heartwood of Dalbergia odorifera on nitric oxide production in RAW 264.7 macrophages.
AID1073037Cytotoxicity against MDCK cells after 72 hrs2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Computer-guided approach to access the anti-influenza activity of licorice constituents.
AID1632846Inhibition of mouse MAO-B preincubated for 15 mins followed by addition of kynuramine as substrate measured after 30 mins by fluorometric analysis2016Bioorganic & medicinal chemistry letters, 10-01, Volume: 26, Issue:19
Potent selective monoamine oxidase B inhibition by maackiain, a pterocarpan from the roots of Sophora flavescens.
AID338056Antifungal activity against Penicillium expansum ATCC 7861 after 3 days by microdilution assay
AID1171163Inhibition of RANKL-stimulated IkappaBalpha degradation in ICR mouse BMMC at 1 to 10 uM incubated for 4 hrs by Western blotting method2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway.
AID404183Cytotoxicity against human HeLa cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID1166543Effect on adipogenesis in mouse 3T3L1 cells assessed as reduction in Fabp4 gene expression at 5 to 50 uM after 8 days by real time quantitative PCR analysis relative to vehicle-treated control2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPARγ partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes.
AID1171167Inhibition of RANKL-stimulated AKT phosphorylation in ICR mouse BMMC at 1 to 10 uM incubated for 12 hrs by Western blotting method2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway.
AID1171162Inhibition of RANKL-stimulated NFkappaB p65 phosphorylation in ICR mouse BMMC at 1 to 10 uM incubated for 4 hrs by Western blotting method2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway.
AID377884Toxicity in C57B mouse assessed as induction of adverse effect on appearance at 40 mg/kg, po administered once daily for 3 days2000Journal of natural products, Oct, Volume: 63, Issue:10
Antigiardial activity of isoflavones from Dalbergia frutescens bark.
AID1166546Effect on adipogenesis in mouse 3T3L1 cells assessed as reduction in Cebpa gene expression at 5 to 50 uM after 4 days by real time quantitative PCR analysis relative to vehicle-treated control2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPARγ partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes.
AID666609Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and antitumor activity of formononetin nitrogen mustard derivatives.
AID745311Inhibition of Helicobacter pylori ATCC 43504 urease-mediated ammonia production preincubated for 1.5 hrs by indophenol method2013European journal of medicinal chemistry, May, Volume: 63Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.
AID1227826Anti-neuroinflammatory activity against mouse BV2 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess assay2015Bioorganic & medicinal chemistry letters, Jan-01, Volume: 25, Issue:1
Natural therapeutic agents for neurodegenerative diseases from a traditional herbal medicine Pongamia pinnata (L.) Pierre.
AID1166556Reduction in triglyceride release in mouse 3T3L1 cells at 50 uM after 48 hrs by fluorescence-based AdipoRed assay2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPARγ partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes.
AID398785Antibacterial activity against Klebsiella pneumoniae ATCC 10031 at 100 mcg/ml by agar-dilution streak method
AID681379TP_TRANSPORTER: inhibition of EGCG in MRP1-expressing MDCKII cells2003Biochemical and biophysical research communications, Oct-10, Volume: 310, Issue:1
Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites.
AID1764435Binding affinity to pig pancreatic lipase type 2 assessed as binding constant at 27 degC measured after 1 min by Stern-Volmer plot analysis2021Journal of natural products, 03-26, Volume: 84, Issue:3
Natural Isoflavones and Semisynthetic Derivatives as Pancreatic Lipase Inhibitors.
AID1372143Inhibition of human CYP1B1 expressed in yeast microsomal membranes at 10 uM using 7-ethoxyresorufin as substrate by fluorescence assay relative to control
AID1166548Effect on adipogenesis in mouse 3T3L1 cells assessed as reduction in Fabp4 gene expression at 5 to 50 uM after 4 days by real time quantitative PCR analysis relative to vehicle-treated control2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPARγ partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes.
AID334924Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed as early antigen induction at 10 molar ratio after 48 hrs by indirect immunofluorescence technique relative to TPA
AID338052Antibacterial activity against Staphylococcus aureus ATCC 25923 after 16 hrs by microdilution assay
AID492140Antioxidant activity assessed as formazan formation induced absorbance changes at 25 ppm at 570 nm at 37 degC for 6 hrs by MTT assay2010Journal of natural products, Jul-23, Volume: 73, Issue:7
An efficient and economical MTT assay for determining the antioxidant activity of plant natural product extracts and pure compounds.
AID1632840Selectivity index, ratio of IC50 for recombinant human MAO-A expressed in baculovirus infected BTI insect cells to IC50 for recombinant human MAO-B expressed in baculovirus infected BTI insect cells2016Bioorganic & medicinal chemistry letters, 10-01, Volume: 26, Issue:19
Potent selective monoamine oxidase B inhibition by maackiain, a pterocarpan from the roots of Sophora flavescens.
AID1764436Binding affinity to pig pancreatic lipase type 2 assessed as binding constant at 32 degC measured after 1 min by Stern-Volmer plot analysis2021Journal of natural products, 03-26, Volume: 84, Issue:3
Natural Isoflavones and Semisynthetic Derivatives as Pancreatic Lipase Inhibitors.
AID332399Cytotoxicity against human MCF7 cells after 7 days1994Journal of natural products, Mar, Volume: 57, Issue:3
Kneglomeratanol, kneglomeratanones A and B, and related bioactive compounds from Knema glomerata.
AID1764427Binding affinity to pig pancreatic lipase type 2 assessed as decrease in fluorescence intensity at 32 degC measured after 1 min by fluorescence spectral analysis2021Journal of natural products, 03-26, Volume: 84, Issue:3
Natural Isoflavones and Semisynthetic Derivatives as Pancreatic Lipase Inhibitors.
AID439372Agonist activity at human PPARalpha expressed in HEK293 cells co-transfected with PPRE assessed as beta-galactosidase signal at 40 uM after 48 hrs by reporter gene assay relative to control2009Journal of medicinal chemistry, Nov-12, Volume: 52, Issue:21
7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists.
AID401477Displacement of [3H]diazepam from benzodiazepine receptor in rat cerebral cortex membrane
AID1372142Inhibition of recombinant human CYP1A1 expressed in yeast microsomal membranes at 10 uM by fluorescence assay relative to control
AID1764431Binding affinity to pig pancreatic lipase type 2 assessed as bathochromic shift of maximum fluorescence intensity at 37 degC measured after 1 min by fluorescence spectral analysis2021Journal of natural products, 03-26, Volume: 84, Issue:3
Natural Isoflavones and Semisynthetic Derivatives as Pancreatic Lipase Inhibitors.
AID1166547Effect on adipogenesis in mouse 3T3L1 cells assessed as reduction in Srebf1 gene expression at 5 to 50 uM after 4 days by real time quantitative PCR analysis relative to vehicle-treated control2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPARγ partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes.
AID1166573Partial agonist activity at PPAR-gamma in mouse embryo fibroblast assessed as reduction in activation at 5 to 50 uM by transactivation assay in presence of rosiglitazone2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPARγ partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes.
AID1764430Binding affinity to pig pancreatic lipase type 2 assessed as bathochromic shift of maximum fluorescence intensity at 32 degC measured after 1 min by fluorescence spectral analysis2021Journal of natural products, 03-26, Volume: 84, Issue:3
Natural Isoflavones and Semisynthetic Derivatives as Pancreatic Lipase Inhibitors.
AID377879Cytotoxicity against african green monkey Vero cells up to 50 ug/mL after 48 hrs by neutral red dye assay2000Journal of natural products, Oct, Volume: 63, Issue:10
Antigiardial activity of isoflavones from Dalbergia frutescens bark.
AID469804Estrogenic activity in luciferase transfected human MCF7 cells assessed as drug level causing stimulation of cell proliferation equivalent to 100 pM estradiol by luciferase reporter gene assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID1171152Toxicity against ICR mouse BMMC assessed as reduction in cell viability up to 100 uM after 72 hrs by WST8 assay2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway.
AID1484040Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production at 10 uM after 24 hrs by Griess assay relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Glycybridins A-K, Bioactive Phenolic Compounds from Glycyrrhiza glabra.
AID266704Antiproliferative activity against human NCI60 cell line2006Journal of medicinal chemistry, Jun-29, Volume: 49, Issue:13
Structural studies on bioactive compounds. 40.(1) Synthesis and biological properties of fluoro-, methoxyl-, and amino-substituted 3-phenyl-4H-1-benzopyran-4-ones and a comparison of their antitumor activities with the activities of related 2-phenylbenzot
AID1070247Antiprotozoal activity against trophozoite stage of Giardia lamblia IMSS:8909:1 assessed as growth inhibition after 48 hrs2014Bioorganic & medicinal chemistry, Feb-15, Volume: 22, Issue:4
Synthesis of 3-tetrazolylmethyl-4H-chromen-4-ones via Ugi-azide and biological evaluation against Entamoeba histolytica, Giardia lamblia and Trichomona vaginalis.
AID1484048Antiproliferative activity against human SW480 cells at 10 uM after 24 hrs by MTS assay relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Glycybridins A-K, Bioactive Phenolic Compounds from Glycyrrhiza glabra.
AID295284Inhibition of human SGLT2 expressed in COS1 cells assessed as [14C]methyl-alpha-D-glucopyranoside uptake at 50 uM2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Na+-glucose cotransporter (SGLT) inhibitory flavonoids from the roots of Sophora flavescens.
AID1156797Binding affinity to IL-2 (unknown origin)2014European journal of medicinal chemistry, Aug-18, Volume: 83Prediction of anti-tumor chemical probes of a traditional Chinese medicine formula by HPLC fingerprinting combined with molecular docking.
AID1171154Inhibition of RANKL protein expression in ICR mouse BMMC co-cultured with primary osteoblasts at 1 to 10 uM incubated for 48 hrs by ELISA method relative to untreated control2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway.
AID366286Inhibition of Influenza A Jiangsu/10/2003 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay2008Bioorganic & medicinal chemistry, Aug-01, Volume: 16, Issue:15
Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities.
AID1437590Cytotoxicity against human EC109 cells assessed as inhibition of cell viability after 48 hrs by MTT assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Design and synthesis of formononetin-dithiocarbamate hybrids that inhibit growth and migration of PC-3 cells via MAPK/Wnt signaling pathways.
AID334922Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed as early antigen induction at 1000 molar ratio after 48 hrs by indirect immunofluorescence technique relative to TPA
AID377881Toxicity in C57B mouse assessed as induction of adverse feeding behavior at 40 mg/kg, po administered once daily for 3 days2000Journal of natural products, Oct, Volume: 63, Issue:10
Antigiardial activity of isoflavones from Dalbergia frutescens bark.
AID398784Antibacterial activity against Salmonella gallinarum ATCC 9184 at 100 mcg/ml by agar-dilution streak method
AID305717Antiproliferative activity against human U937 cells after 72 hrs by WST-8 assay2007Bioorganic & medicinal chemistry, Feb-01, Volume: 15, Issue:3
Rotenoids and flavonoids with anti-invasion of HT1080, anti-proliferation of U937, and differentiation-inducing activity in HL-60 from Erycibe expansa.
AID666610Cytotoxicity against human DU145 cells after 72 hrs by MTT assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and antitumor activity of formononetin nitrogen mustard derivatives.
AID1171169Inhibition of RANKL-stimulated JNK phosphorylation in ICR mouse BMMC at 1 to 10 uM incubated for 12 hrs by Western blotting method2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway.
AID1166557Reduction in triglyceride release in mouse 3T3L1 cells at 50 uM after 48 hrs by oil red o assay2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
2-(2-Bromophenyl)-formononetin and 2-heptyl-formononetin are PPARγ partial agonists and reduce lipid accumulation in 3T3-L1 adipocytes.
AID1386836Antagonist activity at PR-b (unknown origin) expressed in Ishikawa cells assessed as inhibition of progesterone-induced PRE activity at >= 25 uM after 24 hrs by luciferase reporter gene based luminescence assay2018Journal of natural products, 09-28, Volume: 81, Issue:9
Irilone from Red Clover ( Trifolium pratense) Potentiates Progesterone Signaling.
AID469801Estrogenic activity in human T47D cells assessed as drug level causing stimulation of cell proliferation equivalent to 100 pM estradiol after 96 hrs by alamar blue assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID1484042Inhibition of LPS-induced NF-kappaB (unknown origin) transactivation expressed in human SW480 cells at 10 uM administered 1 hr after LPS stimulation measured after 6 hrs by luciferase reporter gene assay relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Glycybridins A-K, Bioactive Phenolic Compounds from Glycyrrhiza glabra.
AID334927Cytotoxicity against human Raji cells assessed as cell viability at 100 molar ratio
AID1437589Cytotoxicity against human MGC803 cells assessed as inhibition of cell viability after 48 hrs by MTT assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Design and synthesis of formononetin-dithiocarbamate hybrids that inhibit growth and migration of PC-3 cells via MAPK/Wnt signaling pathways.
AID1171165Inhibition of RANKL-stimulated NFkappaB (unknown origin) expressed in ICR mouse BMMC assessed as reduction in transcriptional activity at 1 to 10 uM incubated for 12 hrs by SEAP based reporter gene assay2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway.
AID398780Antibacterial activity against Staphylococcus aureus ATCC 13709 at 100 mcg/ml by agar-dilution streak method
AID1484037Inhibition of recombinant human PTP1B using pNPP as substrate at 10 uM after 30 mins relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Glycybridins A-K, Bioactive Phenolic Compounds from Glycyrrhiza glabra.
AID1243357Antioxidant activity assessed as reduction of Fe3+ to Fe2+ after 20 mins2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Isolation and structure elucidation of bioactive compounds from the roots of the Tunisian Ononis angustissima L.
AID1453615Growth inhibition of human SW480 cells at 10 uM after 24 hrs by MTS assay relative to control2017Bioorganic & medicinal chemistry, 07-15, Volume: 25, Issue:14
Screening for bioactive natural products from a 67-compound library of Glycyrrhiza inflata.
AID1156795Retention time of the compound by chromatography2014European journal of medicinal chemistry, Aug-18, Volume: 83Prediction of anti-tumor chemical probes of a traditional Chinese medicine formula by HPLC fingerprinting combined with molecular docking.
AID1463920Activation of Nrf2 (unknown origin) expressed in human HepG2 cells at 10 uM incubated for 6 hrs by ARE-driven luciferase reporter gene assay relative to untreated control2017Bioorganic & medicinal chemistry, 10-15, Volume: 25, Issue:20
Nrf2 activators from Glycyrrhiza inflata and their hepatoprotective activities against CCl
AID1484034Inhibition of tyrosinase (unknown origin) using L-tyrosine as substrate at 10 uM preincubated for 15 mins followed by substrate addition relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Glycybridins A-K, Bioactive Phenolic Compounds from Glycyrrhiza glabra.
AID439371Agonist activity at human PPARalpha expressed in HEK293 cells co-transfected with PPRE assessed as beta-galactosidase signal at 25 uM after 48 hrs by reporter gene assay relative to control2009Journal of medicinal chemistry, Nov-12, Volume: 52, Issue:21
7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists.
AID469800Estrogenic activity in human MCF7 cells assessed as drug level causing stimulation of cell proliferation equivalent to 100 pM estradiol after 96 hrs by alamar blue assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID1632845Inhibition of mouse MAO-A preincubated for 15 mins followed by addition of kynuramine as substrate measured after 30 mins by fluorometric analysis2016Bioorganic & medicinal chemistry letters, 10-01, Volume: 26, Issue:19
Potent selective monoamine oxidase B inhibition by maackiain, a pterocarpan from the roots of Sophora flavescens.
AID469799Estrogenic activity in human T47D cells assessed as drug level causing stimulation of cell proliferation equivalent to 10 pM estradiol after 96 hrs by alamar blue assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (465)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (1.94)18.7374
1990's21 (4.52)18.2507
2000's98 (21.08)29.6817
2010's244 (52.47)24.3611
2020's93 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 41.44

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index41.44 (24.57)
Research Supply Index6.20 (2.92)
Research Growth Index5.33 (4.65)
Search Engine Demand Index61.68 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (41.44)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials10 (2.07%)5.53%
Reviews15 (3.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other458 (94.82%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Effects of Red Clover Treatment on Bone Tissue Regulation in Postmenopausal Osteopenia. [NCT02174666]85 participants (Actual)Interventional2014-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]